
<html lang="en"     class="pb-page"  data-request-id="04b9b993-659f-40c5-b8f2-5cfc631179f5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-11;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm5017895;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutant β-N-acetylhexosaminidase Activity" /></meta><meta name="dc.Creator" content="Michael B.  Tropak" /></meta><meta name="dc.Creator" content="Jianmin  Zhang" /></meta><meta name="dc.Creator" content="Sayuri  Yonekawa" /></meta><meta name="dc.Creator" content="Brigitte A.  Rigat" /></meta><meta name="dc.Creator" content="Virender S.  Aulakh" /></meta><meta name="dc.Creator" content="Matthew R.  Smith" /></meta><meta name="dc.Creator" content="Hee-Jong  Hwang" /></meta><meta name="dc.Creator" content="Marco A.  Ciufolini" /></meta><meta name="dc.Creator" content="Don J.  Mahuran" /></meta><meta name="dc.Description" content="In order to identify structural features of pyrimethamine (5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine) that contribute to its inhibitory activity (IC50 value) and chaperoning efficacy toward ..." /></meta><meta name="Description" content="In order to identify structural features of pyrimethamine (5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine) that contribute to its inhibitory activity (IC50 value) and chaperoning efficacy toward ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 2, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5017895" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5017895" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5017895" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5017895" /></link>
        
    
    

<title>Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutant β-N-acetylhexosaminidase Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5017895" /></meta><meta property="og:title" content="Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutant β-N-acetylhexosaminidase Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0009.jpeg" /></meta><meta property="og:description" content="In order to identify structural features of pyrimethamine (5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine) that contribute to its inhibitory activity (IC50 value) and chaperoning efficacy toward β-N-acetylhexosaminidase, derivatives of the compound were synthesized that differ at the positions bearing the amino, ethyl, and chloro groups. Whereas the amino groups proved to be critical to its inhibitory activity, a variety of substitutions at the chloro position only increased its IC50 by 2–3-fold. Replacing the ethyl group at the 6-position with butyl or methyl groups increased IC50 more than 10-fold. Surprisingly, despite its higher IC50, a derivative lacking the chlorine atom in the para-position was found to enhance enzyme activity in live patient cells a further 25% at concentrations &gt;100 μM, while showing less toxicity. These findings demonstrate the importance of the phenyl group in modulating the chaperoning efficacy and toxicity profile of the derivatives." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5017895"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5017895">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5017895&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5017895&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5017895&amp;href=/doi/10.1021/jm5017895" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4483-4493</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5018175" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00451" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutant β-<i>N</i>-acetylhexosaminidase Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+B.++Tropak">Michael B. Tropak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianmin++Zhang">Jianmin Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sayuri++Yonekawa">Sayuri Yonekawa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brigitte+A.++Rigat">Brigitte A. Rigat</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Virender+S.++Aulakh">Virender S. Aulakh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+R.++Smith">Matthew R. Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hee-Jong++Hwang">Hee-Jong Hwang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco+A.++Ciufolini">Marco A. Ciufolini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Don+J.++Mahuran">Don J. Mahuran</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Genetics and Genome Biology, SickKids, PGCRL 686 Bay Street, Toronto, Ontario M5G 0A4, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Chemistry, University of British Columbia, 2036 Main Mall Vancouver, British Columbia V6T 1Z1, Canada</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Laboratory Medicine and Pathology, University of Toronto, Medical Science Building, 1 King’s College Circle, 6th Floor, Toronto, Ontario M5S 1A8, Canada</span></div><div class="corresp-info"><strong>*</strong>Phone: (416) 813-6161. E-mail: <a href="/cdn-cgi/l/email-protection#cea6abb68ebda7ada5a5a7aabde0adaf"><span class="__cf_email__" data-cfemail="147c716c54677d777f7f7d70673a7775">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5017895&amp;href=/doi/10.1021%2Fjm5017895" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4483–4493</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 18, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 November 2014</li><li><span class="item_label"><b>Published</b> online</span>2 June 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 June 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5017895" title="DOI URL">https://doi.org/10.1021/jm5017895</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4483%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BB.%2BTropak%252C%2BJianmin%2BZhang%252C%2BSayuri%2BYonekawa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D11%26contentID%3Djm5017895%26title%3DPyrimethamine%2BDerivatives%253A%2BInsight%2Binto%2BBinding%2BMechanism%2Band%2BImproved%2BEnhancement%2Bof%2BMutant%2B%25CE%25B2-N-acetylhexosaminidase%2BActivity%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4493%26publicationDate%3DJune%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5017895"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">927</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5017895" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutant β-N-acetylhexosaminidase Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;B. Tropak&quot;},{&quot;first_name&quot;:&quot;Jianmin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Sayuri&quot;,&quot;last_name&quot;:&quot;Yonekawa&quot;},{&quot;first_name&quot;:&quot;Brigitte&quot;,&quot;last_name&quot;:&quot;A. Rigat&quot;},{&quot;first_name&quot;:&quot;Virender&quot;,&quot;last_name&quot;:&quot;S. Aulakh&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;R. Smith&quot;},{&quot;first_name&quot;:&quot;Hee-Jong&quot;,&quot;last_name&quot;:&quot;Hwang&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;A. Ciufolini&quot;},{&quot;first_name&quot;:&quot;Don&quot;,&quot;last_name&quot;:&quot;J. Mahuran&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;4483-4493&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5017895&quot;},&quot;abstract&quot;:&quot;In order to identify structural features of pyrimethamine (5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine) that contribute to its inhibitory activity (IC50 value) and chaperoning efficacy toward β-N-acetylhexosaminidase, derivatives of the compound were synthesized that differ at the positions bearing the amino, ethyl, and chloro groups. Whereas the amino groups proved to be critical to its inhibitory activity, a variety of substitutions at the chloro position only increased its IC50 by 2–3-fold. Replacing the ethyl group at the 6-position with butyl or methyl groups increased IC50 more than 10-fold. Surprisingly, despite its higher IC50, a derivative lacking the chlorine atom in the para-position was found to enhance enzyme activity in live patient cells a further 25% at concentrations &gt;100 μM, while showing less toxicity. These findings demonstrate the importance of the phenyl group in modulating the chaperoning efficacy and toxicity profile of the derivatives.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017895&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017895" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017895&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017895" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017895&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017895" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5017895&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017895&amp;href=/doi/10.1021/jm5017895" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5017895" /></input><a href="/doi/pdf/10.1021/jm5017895" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5017895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5017895%26sid%3Dliteratum%253Aachs%26pmid%3D25984755%26genre%3Darticle%26aulast%3DTropak%26date%3D2015%26atitle%3DPyrimethamine%2BDerivatives%253A%2BInsight%2Binto%2BBinding%2BMechanism%2Band%2BImproved%2BEnhancement%2Bof%2BMutant%2B%25CE%25B2-N-acetylhexosaminidase%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D11%26spage%3D4483%26epage%3D4493%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jmcmar.2015.58.issue-11/20150611/jmcmar.2015.58.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In order to identify structural features of pyrimethamine (5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine) that contribute to its inhibitory activity (IC<sub>50</sub> value) and chaperoning efficacy toward β-<i>N</i>-acetylhexosaminidase, derivatives of the compound were synthesized that differ at the positions bearing the amino, ethyl, and chloro groups. Whereas the amino groups proved to be critical to its inhibitory activity, a variety of substitutions at the chloro position only increased its IC<sub>50</sub> by 2–3-fold. Replacing the ethyl group at the 6-position with butyl or methyl groups increased IC<sub>50</sub> more than 10-fold. Surprisingly, despite its higher IC<sub>50</sub>, a derivative lacking the chlorine atom in the <i>para</i>-position was found to enhance enzyme activity in live patient cells a further 25% at concentrations >100 μM, while showing less toxicity. These findings demonstrate the importance of the phenyl group in modulating the chaperoning efficacy and toxicity profile of the derivatives.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72021" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72021" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pyrimethamine (PYR, <b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>A) is a known human anti-malarial drug that inhibits the parasite’s (e.g., <i>Plasmodium falciparum</i>) dihydrofolate reductase (DHFR).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Interestingly, the compound also acts as an effective pharmacological chaperone (PC) for lysosomal β-<i>N</i>-acetylhexosaminidase A (Hex A).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Indeed, we have shown that, in some late-onset forms of GM2 gangliosidosis (Tay-Sachs and Sandhoff diseases), the Hex A activity in patient fibroblasts can be enhanced by 2–3-fold.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Recently it has been reported that treating Dutch APP<sup>E693Q</sup> mice (a mouse model of Alzheimer’s disease) with a PC for Hex dramatically reduced the accumulation of a β-amyloid peptide:ganglioside (GM2 and GM3) complex. This reduction was associated with improved learning behavior and decreased anxiety in the treated mice.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Thus, PCs of Hex have the potential to treat a much broader patient base than just those with late-onset Tay-Sachs or Sandhoff disease.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structure of pyrimethamine (PYR). (B) Amino acid residues (green) in the active site involved in binding PYR (yellow). The chlorine atom on PYR is highlighted in red. Residues participating in formation of the active site from the adjacent subunit are shown in marine blue. Amino acid residues (D290, D240, E491) directly forming hydrogen bonds (denoted with dashed blue lines) with the amino (blue) groups on PYR are highlighted in green. The ethyl group of PYR is found in a hydrophobic pocket formed by residues W405 and W424 (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Three Hex isozymes arise through the combinatorial dimerization of two subunits encoded by two evolutionarily related genes, the α (encoded by the <i>HEXA</i> gene) and/or β (<i>HEXB</i> gene), i.e, the major Hex A (αβ) and Hex B (ββ) isozymes and the minor, unstable Hex S (αα) isozyme.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Of the three Hex isozymes, only heterodimeric Hex A is able to efficiently associate with the GM2 activator protein/GM2 ganglioside (GM2) to form the ternary complex and hydrolyze the non-reducing terminal β-1,4-linked <i>N</i>-acetylgalactosamine from GM2, producing GM3 ganglioside. In the late-onset variants of GM2 gangliosidosis, point mutations in either the α-subunit (Tay-Sachs disease) or the β-subunit (Sandhoff disease)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> reduce the activity of Hex A below a critical threshold of enzyme activity needed to prevent GM2 storage (5–10% of normal values).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Since PYR is a micromolar inhibitor of Hex isozymes (inhibitory activity (IC<sub>50</sub>) = 15 μM), it binds to and stabilizes the folded mutant enzyme in the endoplasmic reticulum (ER), thereby increasing the number of molecules that are able to retain their active folded conformation, allowing the proper disulfide bonds to form and the enzyme to be transported to the lysosome.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The presence of disulfide bonds, the acidic pH of the lysosome, and the presence of substrate all combine to displace PYR while continuing to stabilize Hex A. Additionally, the <i>K</i><sub>i</sub> of PYR as an inhibitor of Hex increases at acidic pH.</div><div class="NLM_p">We have demonstrated experimentally that PYR treatment of late-onset Tay-Sachs patients’ cells loaded with a fluorescent GM2 ganglioside analogue produces an enhancement of the cells’ ability to turnover the substrate.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> However, the chaperoning efficacy of PYR is mutation dependent.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The structure of Hex B in complex with PYR has only recently been elucidated.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Amino acids Asp240 and Glu491 are within hydrogen-bonding distances of the amino groups in PYR and are predicted to act as hydrogen bond acceptors (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B). The ethyl group of PYR is positioned within a hydrophobic pocket formed by Trp405, Trp424, and Trp489. The chlorine atom in the <i>para</i>-position on the phenyl of PYR forms a weak hydrogen bond with a conserved water molecule near the mouth of the substrate-binding pocket and points toward the bulk solvent.</div><div class="NLM_p">PYR has been evaluated in both adult-onset Tay-Sachs disease (ATSD) and Sandhoff disease (ASD) patients in an open-label Phase I/II clinical trial to evaluate treatment efficacy and tolerability.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The observed increase in Hex A activity levels in patients’ leukocytes (up to a maximum of 4-fold) was closely correlated with their plasma levels of PYR, which varied according to the oral dose of the drug (25, 50, 75, or 100 mg/day) and the metabolism of each patient; i.e., patients taking the same dose could have very different levels of plasma PYR. As an anti-malarial, PYR has 1000-fold higher affinity for the parasite versus human DHFR. Patients in this study were supplemented with folic acid (leucovorin) as a precaution against human DHFR inhibition. Nonetheless, side effects were seen in most patients treated with PYR at or above 75 mg or with plasma levels >1.5 mg/L. Therefore, it would be desirable to obtain derivatives of PYR that enhance Hex activity while concomittantly minimizing undesirable side effects.</div><div class="NLM_p last">In order to identify features of PYR that contribute to its Hex inhibitory activity and chaperoning efficacy, i.e., PC activity, as well as possibly contributing to the detrimental side effects seen at higher doses, derivatives of the compound were synthesized. These differed from PYR at the positions bearing the amino, ethyl, and chloro groups. Whereas the amino groups and the ethyl group at the 5-position proved to be critical for its PC activity, a variety of substitutions at the chloro position only increased the IC<sub>50</sub> by 2–3-fold. Surprisingly, the derivatives lacking the pendant chloro group were found to enhance enzyme activity in live patient cells by a further 25% at concentrations >100 μM, despite their higher IC<sub>50</sub>. Combined with the 3D structure of the Hex A, these derivatives have provided additional insight into the binding mechanism of PYR, as well as into features associated with improved chaperoning efficacy and reduced toxicity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38154" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38154" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To gain insight into the molecular details of how PYR binds to Hex, and to identify PYR derivatives with improved enzyme enhancement efficacy in terms of dosing and response, three regions of <b>1</b> (PYR) were modified: (1) the 2,4-diamino groups on the pyrimidine backbone, (2) the 6-ethyl alkyl side chain, and (3) the phenyl group itself or the substituents on the phenyl group attached to the pyrimidine ring.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of PYR Analogues</h3><div class="NLM_p">Analogues of PYR retaining the 2,4-diaminopyrimidine motif were prepared according to published procedures<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, which also lists the structures of representative compounds examined in the course of this study. Deaminated variants of <b>1</b> and <b>5g</b> were obtained starting with vigorous acid hydrolysis of the parent compounds,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> followed by reaction of the emerging pyrimidinones with POCl<sub>3</sub> and hydrogenolysis of the resultant chloropyrimidines (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Pyrimidines such as <b>11</b> were prepared in a like fashion from compounds of the type <b>10</b>, which in turn were obtained by reaction of an appropriately substituted compound <b>4</b> with urea in EtOH–EtONa.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Procedure for Synthesis of PYR Analogues and Representative Compounds Examined in This Study</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Des-amino Analogues of <b>1</b> and <b>5g</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Inhibitory Activity of the Deaminated Analogues of PYR</h3><div class="NLM_p">Enzyme activity of purified human Hex A in the presence of the different PYR analogues was monitored using the colorimetric substrate <i>p</i>-nitrophenyl-β-<span class="smallcaps smallerCapital">d</span>-<i>N</i>-acetylglucopyranoside (pNPGlcNAc) (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Removal of one (cf. <b>8</b>, <b>9</b>) or both (cf. <b>11</b>) amino groups from the pyrimidine ring resulted in a >10-fold increase in IC<sub>50</sub> values (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Substitution of the 4-amino group with a carbonyl (cf. <b>6</b>) also resulted in a >120-fold increase in IC<sub>50</sub>. Both amino groups are therefore essential for activity. This is consistent with their role as H-bond donors within the active site of the enzyme deduced from the 3D structure of the HexB:PYR complex.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biological Activities of Some Des-amino PYR Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>1</b></th><th class="colsep0 rowsep0" align="center"><b>6</b></th><th class="colsep0 rowsep0" align="center"><b>8</b></th><th class="colsep0 rowsep0" align="center"><b>9</b></th><th class="colsep0 rowsep0" align="center"><b>11</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">17 ± 3</td><td class="colsep0 rowsep0" align="center">>2100</td><td class="colsep0 rowsep0" align="center">>400</td><td class="colsep0 rowsep0" align="center">>400</td><td class="colsep0 rowsep0" align="center">>940</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PC activity<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">2.1 ± 0.1</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td><td class="colsep0 rowsep0" align="center">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> (μM) determined using purified human Hex A and pNPGlcNAc (0.5 mM).</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">PC activity: Intracellular enhancement (increase in) of enzyme activity based on the ratio of Hex A activity in treated ATSD patient fibroblasts versus mock treated (DMSO). Enzyme activity was based on the hydrolysis of the α-active-site specific MUGS (1.6 mM) by lysates from treated and untreated ATSD patient fibroblasts.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Inhibitory Activity of PYR Analogues with Modified 6-Alkyl Side Chains</h3><div class="NLM_p">Shortening of the alkyl side chain from an ethyl to methyl side arm resulted in a more than 25-fold increase in IC<sub>50</sub> values, i.e., from 17 to 560 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Similarly, increasing the length beyond a propyl or introducing a branched chain, such as isopropyl, also resulted in a more than 20-fold increase in IC<sub>50</sub> values relative to PYR. By comparison, the IC<sub>50</sub> of the propyl derivative was not significantly different than that of PYR. These results are in line with the size of a hydrophobic pocket formed by Trp residues 405, 424, and 489 that can, in the context of a 6-alkyl side chain on PYR, accommodate an ethyl or propyl but not a bulkier group, such as butyl or isopropyl.<a onclick="showRef(event, 'ref9 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref12">(9, 12)</a> A similar trend in increasing  IC<sub>50</sub> was observed with thiazoline derivatives that contained analogously positioned alkyl chains of increasing size.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of the Side-Chain Length on the Biological Activity of PYR Analogues <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">PC activity<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">4-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">17 ± 3</td><td class="colsep0 rowsep0" align="center">2.1 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">4-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="center">>560</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">4-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left"><i>n</i>-Pr</td><td class="colsep0 rowsep0" align="center">18 ± 3</td><td class="colsep0 rowsep0" align="center">1.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">4-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Pr</td><td class="colsep0 rowsep0" align="center">>410</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">4-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left"><i>n</i>-Bu</td><td class="colsep0 rowsep0" align="center">>1400</td><td class="colsep0 rowsep0" align="center">–</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">4-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="center">180 ± 20</td><td class="colsep0 rowsep0" align="center">–</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> (μM): see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, footnote <i>a</i>.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">PC activity: see  Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, footnote <i>b</i>.</p></div></div></div><div class="NLM_p last">The general acid–base residue of Hex B (Glu355) is located near the hydrophobic pocket, and its proximity suggested that replacing the alkyl side chain with an amino group would improve binding via formation of an additional electrostatic interaction. However, substitution of the 6-ethyl group with methylamine resulted in a >10-fold increase in the IC<sub>50</sub>, whereas replacement with an azidomethyl group did not significantly affect the IC<sub>50</sub> value.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Inhibitory Activity of PYR Analogues with Modified Aryl Groups</h3><div class="NLM_p">Bateman et al. in 2011 demonstrated that the chlorine atom on the phenyl group makes a hydrogen bond with a water molecule located near the entrance to the active site of Hex; however, the phenyl ring was found to project toward the bulk solvent, suggesting that a larger variety of substitutions could be accommodated on the underlying ring without greatly affecting its binding affinity toward the enzyme.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Several PYR derivatives, differing in terms of the pendant group (chloro, methyl, methoxy, or trifluoromethyl) and their relative position (<i>meta</i>, <i>para</i>, or <i>ortho</i>) on the phenyl ring, were synthesized and evaluated for inhibitory activity and chaperoning efficacy. Representative examples are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Derivatives incorporating a <i>para</i>-substituted phenyl group (<b>5f</b>, <b>5g</b>, and <b>5i</b>), irrespective of the nature of the substituent, displayed an average IC<sub>50</sub> value (24 ± 13 μM) similar to that of PYR (17 ± 3 μM). Collectively, this group of compounds, including PYR, will be referred to as the PYR analogues bearing a <i>para</i>-substituted phenyl group. In contrast, analogues containing an <i>ortho</i>- or <i>meta</i>-substituted phenyl group (<b>5j</b>, <b>5k</b>, <b>5l</b>) and/or lacking a substituent in the <i>para</i>-position (<b>5h</b>) on average showed a 2.4-fold higher IC<sub>50</sub> (41 ± 5 μM) compared to PYR. Collectively, this group of compounds is referred to as the PYR analogues lacking a <i>para</i>-substituted phenyl group. The increased IC<sub>50</sub> values associated with this group of compounds may reflect the steric clashes of <i>ortho-</i> and <i>meta-</i>positioned pendant groups with the residues at the entrance to the active site, due to the of axial rotation of the phenyl group. Such steric clashes would be minimized in the <i>para</i>-positioned PYR analogues.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effect of Phenyl Group Substitution on the Biological Activity of PYR Analogues <b>5</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">PC activity<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">4-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">17 ± 3</td><td class="colsep0 rowsep0" align="center">2.1 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">4-MeO-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">18 ± 6</td><td class="colsep0 rowsep0" align="center">2.0 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">4-CF<sub>3</sub>-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">15 ± 2</td><td class="colsep0 rowsep0" align="center">2.2 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">32 ± 5</td><td class="colsep0 rowsep0" align="center">2.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="left">4-Me-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">40 ± 16</td><td class="colsep0 rowsep0" align="center">1.7 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5j</b></td><td class="colsep0 rowsep0" align="left">3-Me-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">34 ± 7</td><td class="colsep0 rowsep0" align="center">2.9 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="left">2-Me-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">43 ± 4</td><td class="colsep0 rowsep0" align="center">2.3 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5l</b></td><td class="colsep0 rowsep0" align="left">3,5-di-Me-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="center">47 ± 6</td><td class="colsep0 rowsep0" align="center">2.5 ± 0.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> (μM): see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, footnote <i>a</i>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">PC activity: see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, footnote <i>b</i>.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chaperoning Efficacy of PYR Derivatives</h3><div class="NLM_p last">To compare the enzyme enhancement efficacy of the PYR derivatives in Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, fibroblasts from a patient with ATSD were treated for 5 days with the different PYR derivatives. Only compounds with an IC<sub>50</sub> value of less than 100 μM were evaluated. Although the IC<sub>50</sub> values of PYR and <b>5b</b> differed by less than 20%, they diverged significantly in their ability to enhance mutant (G269S) Hex A activity in ATSD patient fibroblasts. Whereas PYR treatment resulted in a maximal increase of 2.1-fold in Hex A activity, the larger propyl derivative (<b>5b</b>) showed only a 1.5-fold increase, a relative decrease of 35% in chaperoning efficacy. This underscores the importance of the size of the 6-alkyl chain, and given its importance in binding, it is unlikely that any further modifications of this group would lead to an improved level of enhancement. On the other hand, the relatively minor effect on IC<sub>50</sub> values (approximately 2–3-fold increase) associated with changing the pendant group linked to the 5-phenyl ring alludes to the potential for increasing the chaperoning potency of the PYR derivatives by modifying the aryl group.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Chaperoning Efficacy of PYR Analogues Bearing a Modified Aryl Group</h3><div class="NLM_p">The group of PYR analogues <b>bearing</b> a pendant group in the <i>para</i>-position on the phenyl ring (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>: <b>5f</b>, <b>5g</b>, and <b>5i</b>) enhanced intracellular mutant Hex A activity in ATSD patient fibroblasts (2.0 ± 0.3-fold average enhancement) to a similar degree as PYR (2.1 ± 0.1-fold). In contrast, the PYR derivatives <b>lacking</b> a pendant group in the <i>para-</i>position (<b>5j</b>, <b>5k</b>, <b>5l</b>, and <b>5h</b>) on average enhanced intracellular Hex A activity to a greater degree (30% higher values, i.e., 2.6 ± 0.3-fold enhancement) than either PYR (2.1 ± 0.1-fold) or the derivatives incorporating a <i>para</i>-substituted phenyl group (2.0 ± 0.3-fold). These results demonstrated that derivatives <b>lacking</b> a substituent at the <i>para</i>-position on the phenyl moiety generally showed an enhanced ability to increase the intracellular activity of mutant Hex A in ATSD patients, despite having decreased inhibitory activities (higher IC<sub>50</sub>) compared to PYR. Compounds <b>5h</b> and <b>5j</b> produced the greatest maximal increase in mutant Hex A activity in ATSD patient fibroblasts: 2.7- and 2.9-fold, respectively. Among the three, treatment with compound <b>5h</b> demonstrated the least decline in cell viability at the highest concentration employed. The decreased toxicity of <b>5h</b> compared to PYR was confirmed using the Alamar blue assay as an independent readout of cell viability (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Additionally, the nearly identical IC<sub>50</sub> values of the two compounds for human DHFR argue against attributing the disparity in toxicity profiles to their differences in inhibitory activity for the human enzyme. As an alternative target to account for the differential toxicity of PYR and <b>5h</b>, it is interesting to note that PYR is known to significantly decrease phosphorylation of STAT3, which is necessary for its activation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Furthermore, decreased phosphorylation of STAT3 is observed in cells treated with 100 μM PYR. Although these effects were observed in different cells, the concentrations at which these observations were made are very similar to the concentrations (30–100 μM) at which significant toxicity was seen in PYR-treated patient fibroblasts. Activation of STAT3 is required for cell proliferation and cell survival.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> One could speculate that differential effects of PYR and <b>5h</b> on the phosphorylation of STAT3 could account for the variations in the toxicity profiles of the two compounds. Irrespective of the mechanism of action in terms of toxicity, the fact remains that <b>5h</b> appears to be significantly less toxic than PYR, and that this decrease in toxicity likely accounts for the increased chaperoning efficacy of <b>5h</b> at higher concentrations. Therefore, <b>5h</b> and PYR were compared in terms of their effects on intracellular trafficking of Hex A and <i>in cellulo</i> hydrolysis of a GM2 ganglioside derivative at the concentrations that corresponded to each compound’s highest level of chaperone efficacy. A closer examination of the enzyme enhancement capability of the phenyl derivatives over a range of treatment concentrations (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) revealed that the peak increase occurs at a 2–3-fold lower concentration (30–40 μM) for the <i>para</i>-positioned functional groups as compared to those analogues functionalized at other positions (100–140 μM). This treatment range parallels the differences seen in the IC<sub>50</sub> values between the two classes of analogues (i.e., those <b>bearing</b> versus those <b>lacking</b> a <i>para-</i>substitution on the phenyl ring).</div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison of the toxicity of PYR and <b>5h</b> in patient fibroblasts and their respective <i>in vitro</i> inhibitory activity against human DHFR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of <i>in cellulo</i> enhancement of mutant Hex A enzyme activity in ATSD fibroblasts by selected PYR derivatives bearing modifications on the 5-phenyl group at various concentrations, i.e., determination of the level of “maximal increase” for each derivative. Panels (a) <b>5j</b>, circles, and <b>5h</b>, squares; (b) <b>5l</b>, circles, and <b>5k</b>, squares; (c) PYR, circles, and <b>5i</b>, squares; and (d) <b>5g</b>, circles, and <b>5f</b>, squares, all giving the graphical representations of the dose–response curves. Open symbols represent the β-galactosidase (Bgal) activity ratio, which serves as a control for toxicity, e.g., open circles, for each drug, and the same filled symbols, e.g., filled circles, represent the Hex A activity ratio between treated and mock treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The activity level of another lysosomal enzyme (β-galactosidase), which is not inhibited by PYR or its derivatives, was used as a surrogate marker of cell viability. At the highest concentration evaluated (>400 μM), all PYR derivatives, including the parent compound but excluding <b>5h</b>, showed a >60% reduction in β-galactosidase activity, indicative of decreased cell viability. The <i>para</i> class of derivatives exemplified by PYR showed significant signs of declining viability at lower concentrations (<200 μM) compared to the non-<i>para</i> class of compounds, such as <b>5h</b>, which showed a decline in viability at concentrations >200 μM.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Comparison of the Inhibitory Activity of PYR and <b>5h</b> against Different Hex Isozymes and Wild-Type versus Mutant Hex A</h3><div class="NLM_p">As an alternative explanation for the differences in chaperoning efficacy between PYR and <b>5h</b>, it was possible that they exhibited different inhibitory activity toward wild-type versus mutant Hex A. However, their IC<sub>50</sub> values for the wild-type Hex A and B isozymes were similar, differing by less than 30% (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activity of PYR and <b>5h</b> for Different Hex Isozymes at Acidic and Neutral pH</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">pH 4.5</th><th class="rowsep1 colsep0" colspan="2" align="center">pH 4.5</th><th class="rowsep1 colsep0" colspan="2" align="center">pH 7.0</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">Hex A<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Hex B<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Hex A<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> WT</th><th class="colsep0 rowsep0" align="center">Hex A<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> G269S</th><th class="colsep0 rowsep0" align="center">Hex A<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">Hex B<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">8.9 ± 1.1<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">9.1 ± 1.2</td><td class="colsep0 rowsep0" align="center">14 ± 4</td><td class="colsep0 rowsep0" align="center">8.5 ± 3.0</td><td class="colsep0 rowsep0" align="center">3.1 ± 1.0</td><td class="colsep0 rowsep0" align="center">4.5 ± 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="center">30 ± 3</td><td class="colsep0 rowsep0" align="center">38 ± 5</td><td class="colsep0 rowsep0" align="center">27 ± 5</td><td class="colsep0 rowsep0" align="center">27 ± 6</td><td class="colsep0 rowsep0" align="center">11 ± 2</td><td class="colsep0 rowsep0" align="center">15 ± 3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Hex isozymes were purified from human placenta.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">The Hex A isozyme, wild-type (WT), or mutant (G269S) was isolated from lysates of normal or ATSD fibroblasts, respectively, by ion exchange chromatography.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">All IC<sub>50s</sub> (μM) were determined using the universal MUG (1.6 mM) Hex substrate.</p></div></div></div><div class="NLM_p last">The inhibitory activity of <b>5h</b>, like that of PYR, also showed an approximately 2.5-fold decrease in IC<sub>50</sub> values at neutral versus acidic pH. Although it is a relatively small change, both compounds would be expected to bind to the mutant enzyme to a greater degree in the neutral pH of the ER, facilitating protein folding, versus the acidic environment of the lysosome, where the complex needs to dissociate in order for the enzyme to turnover its substrate.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Comparison of Lysosomal Targeting of mutant Hex A by PYR and <b>5h</b></h3><div class="NLM_p">On the basis of protein levels observed by Western blotting (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), peak levels of mature, lysosomally derived Hex α-subunit (∼55 kDa)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> were seen in lysates from ATSD patient cells treated with 33 μg/mL of <b>5h</b> and 11 μg/mL of PYR, relative to mock (1% DMSO) treated cells. Maximal levels of mature Hex α-subunit were higher in <b>5h</b>-treated than in PYR-treated cells. The increased steady-state levels of the Hex subunit protein paralleled the increase in Hex A enzyme activity levels observed in similarly treated ATSD cells (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). These results are suggestive of increased transport of mutant Hex A to the lysosome in ATSD cells treated with <b>5h</b> compared to those treated with PYR. Immunofluorescence staining of <b>5h</b>/PYR-treated versus mock treated patient cells was used as an independent verification of increased transport of mutant Hex A to the lysosomes in the presence of either compound (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). On the basis of fluorescence intensity alone, increased levels of Hex A (green) were observed in both <b>5h</b>- and PYR-treated cells, compared to mock treated cells. Increased colocalization of signals from antibodies directed against Hex A and LAMP1, a lysosomal marker, was further evidence of increased transport of mutant Hex A to lysosomes.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Steady-state protein levels of the Hex α-subunit are increased to a greater degree in <b>5h</b>- versus PYR-treated patient fibroblasts. Lysates from ATSD patient fibroblasts were treated for 5 days with PYR (33 or 11 μg/mL) or <b>5h</b> (33 or 11 μg/mL) and analyzed by Western blotting using a proprietary rabbit polyclonal IgG against human Hex A, followed by anti-rabbit peroxidase conjugated IgG and chemiluminescence detection (ECL kit, Amsersham). Solid and open arrowheads denote position of bands corresponding to the mature (lysosomal) α- and β-subunits of Hex, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Increased colocalization (yellow) of Hex A (green) protein with the lysosomal marker LAMP1 (red), following the treatment of p.G269S/p.G269S α-Hex patient fibroblasts with either <b>5h</b> (33 μg/mL) or PYR (11 μg/mL). Nuclei are shown stained in blue (DAPI). Treated fibroblasts were permeabilized and probed with a proprietary rabbit polyclonal IgG anti-Hex A pre-absorbed with purified human Hex B and a LAMP1 mouse antibody. Primary antibody binding was visualized using the corresponding secondary Alexa Fluor 488 chicken anti-rabbit (green) or Alexa Fluor 594 chicken anti-mouse conjugated antibodies (red). Colocalization of Hex A and LAMP1 staining is shown on panels labeled MERGE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Improved Hydrolysis of a Fluorescent Ganglioside Derivative in Live, PYR-Treated, or <b>5h</b>-Treated Cells</h3><div class="NLM_p">Cell feeding experiments using a fluorescent GM2 ganglioside analogue were used to directly measure intralysosomal hydrolysis of GM2 ganglioside in live ATSD patient cells (i.e., an <i>in cellulo</i> assay).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Fibroblasts from an ATSD patient were first treated with PYR (11 μg/mL) or <b>5h</b> (33 μg/mL) for 10 days to build up their levels of active mutant Hex A prior to feeding the cells with the fluorescent analogue of GM2. The doses of PYR and <b>5h</b> used to treat cells were chosen on the basis of the concentrations previously determined to produce the maximal increases in both Hex A protein and activity (MUGS) levels in treated cells, i.e., the best balance between their chaperoning versus toxicity profiles. Unlike <i>in vitro</i> assays of cell lysates with artificial colorimetric/fluorogenic substrates, <i>in cellulo</i> hydrolysis of the fluorescent GM2 occurs in the lysosomes and requires the mutant enzyme to functionally interact with the GM2 activator protein:GM2 complex. This assay also allows a read-out of any residual inhibition of Hex A caused by the chaperone once the complex enters the lysosome. Following Folch extraction of treated cells, neutral glycolipids (i.e., glycolipids produced further downstream in the GM2 breakdown pathway) in the organic phase and acidic gangliosides in the aqueous phase were resolved by high-performance thin-layer chromatography (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A). Patient cells treated with <b>5h</b> (33 μg/mL) demonstrated a greater intracellular hydrolysis of the fluorescent derivative of GM2 compared to cells treated with PYR (11 μg/mL), as indicated by the higher levels of the band corresponding to GM3. Quantification of the intensity of all bands corresponding to the downstream products of GM3 hydrolysis, lactosylceramide (LacCer) and glucosylceramide (GlcCer) (further hydrolysis was inhibited by the inclusion of an irreversible inhibitor of glucocerebrosidase in the cell feeding assay<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>), in both phases clearly shows increased levels of the products, indicative of increased lysosomal Hex A activity in response to treatment with either compound. However, <b>5h</b> treatment resulted in an additional ∼1.5-fold increase in GM2 hydrolysis in comparison to that of PYR-treated cells (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). A parallel increase is observed in Hex A activity measured in the same lysates using the fluorogenic substrate MUGS (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>C). These results are significant for two reasons. First, there is always a concern that inhibitory molecules acting as PCs could continue inhibiting the activity of Hex A in the lysosome. These results clearly demonstrate that this is not the case for PYR or <b>5h</b>, as a robust increase in GM2 hydrolysis was observed, while it is very likely that, at higher concentrations of either compound, one would eventually see residual inhibition in lysosomes. However, at such higher concentrations, cellular toxicity would also become an issue. Thus, these doses represent the high end of those expected to be used to treat patients. Second, using two orthogonal Hex A enzyme assays, the results clearly and convincingly demonstrate that, at higher concentrations, <b>5h</b> is superior to PYR in enhancing lysosomal levels of Hex A activity. These results are also significant from a therapeutic perspective. Since <b>5h</b> is less toxic at higher concentrations than PYR in cells, it likely could be used at the higher doses in ATSD and ASD patients, which would further enhance Hex A activity beyond the critical threshold necessary to prevent the continuous storage of GM2 gangliosides in their lysosomes.</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Increased intracellular hydrolysis of a fluorescent derivative of GM2 ganglioside in ATSD patient fibroblasts treated with <b>5h</b> or PYR. Hydrolyzed fluorescent GM2 ganglioside derivatives isolated from patient fibroblasts pre-loaded with fluorescent GM2 were resolved by TLC. (A) Chromatograms showing the resolution of metabolized GM2 derivatives in the two phases generated by Folch extraction. (B) Quantification of hydrolyzed levels of ganglioside was derived from the optical density of the bands corresponding to GM3 in the aqueous phase and LacCer and GlcCer in the organic phase. (C) Relative Hex A activity (MUGS) in lysates prepared from the cells used to measure GM2 hydrolysis following treatment with DMSO (Ctrl), PYR, or <b>5h</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The therapeutic potential of <b>5h</b> is predicated on its ability to cross the blood brain barrier (BBB). Pharmacokinetic studies in small animals and quantification of drugs levels in serum and cerebrospinal fluid of PYR-treated GM2 gangliosidosis<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and AIDS<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> patients have clearly demonstrated that PYR crosses the BBB, i.e., enters the nervous system. The physiochemical properties of PYR in terms of number of hydrogen acceptors (4) and calculated LogP (lipophilicity) value (2.8) are congruent with other drugs capable of crossing the BBB.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Thus, the fact that <b>5h</b> is similar to PYR with regard to number of hydrogen acceptors (4) and predicted LogP value (PYR, 2.8, versus <b>5h</b>, 2.2) suggests that <b>5h</b> would also be capable of crossing the BBB—this will need to be verified experimentally.</div><div class="NLM_p last">Recently it has been reported that treating Dutch APP<sup>E693Q</sup> mice (a mouse model of Alzheimer’s disease) with a PC for Hex dramatically reduced the accumulation of a β-amyloid peptide:ganglioside (GM2 and GM3) complex, improved learning behavior, and decreased anxiety.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Indeed, we have preliminary data demonstrating that both PCs, PYR and <b>5h</b>, are able to increase the activity levels of wild-type Hex A by approximately 1.3-fold (<i>p</i> < 0.05) relative to Hex A in DMSO-treated fibroblasts from non-GM2 gangliosidosis patients (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Figure 1S">Supporting Information, Figure 1S</a>). Taken together with the data demonstrating the effectiveness of PYR and <b>5h</b> in enhancing mutant Hex A activity, these observations suggest that these compounds not only could be used to treat some forms of GM2 gangliosidosis but also could be potential therapeutics for Alzheimer’s disease.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have experimentally verified the importance of both amino groups on the pyrimidine ring of PYR and the 6-ethyl side chain in the binding of the molecule to the Hex isozymes, consistent with the predictions derived from the crystal structure of the Hex B:PYR complex. We have demonstrated that, while the phenyl group and its associated moieties do not have a great impact on Hex binding, they significantly increase the ability of the derivatives to enhance the intracellular/lysosomal activity of mutant G269S Hex A. We have identified a PYR derivative, <b>5h</b>, that further increases mutant Hex A activity by another 30% over the maximum observed with PYR. Significantly, we see an increase in the intracellular hydrolysis of GM2 in the lysosomes of fibroblasts treated with this compound. The maximal increase with <b>5h</b> is seen at a higher concentration than with PYR, which is likely caused by the more pronounced negative effects on cellular viability observed with PYR at concentrations >100 μM. As opposed to changes to the amino groups and ethyl arm on the pyrimidine ring, modifications to the phenyl group do not dramatically change the strength of binding, they but appear to decrease the toxicity and thus increase the apparent chaperoning efficacy of the compounds at higher concentrations. As a starting point, modification of the phenyl headgroup represents a site for making further improvements in chaperoning efficacy while minimizing toxicity.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15348" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15348" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Experimental Protocols—Chemistry</h3><div class="NLM_p last">Unless otherwise stated, <sup>1</sup>H (300 MHz) and <sup>13</sup>C (75.5 MHz) NMR spectra were recorded at room temperature (rt). Chemical shifts are reported in parts per million (ppm) on the δ scale, and coupling constants, <i>J</i>, are given in hertz (Hz). Multiplicities are reported as “s” (singlet), “d” (doublet), “t” (triplet), “q” (quartet), “dd” (doublet of doublets), “ddd” (doublet of doublets of doublets), and “m” (multiplet), and further qualified as “br” (broad) or “c” (complex). Infrared (IR) spectra (cm<sup>–1</sup>) were recorded from films deposited on NaCl plates. Mass spectra (<i>m</i>/<i>z</i>) were recorded in the electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI) mode, as indicated. Melting points (mp, uncorrected) were measured on a Mel-Temp apparatus. Commercial reagents and solvents were used without further purification, except for THF (freshly distilled from Na/Ph<sub>2</sub>CO under Ar) and CH<sub>2</sub>Cl<sub>2</sub> (freshly distilled from CaH<sub>2</sub> under Ar). Commercial BuLi solutions were titrated against Ph<sub>2</sub>CHCOOH.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The reactions were monitored by thin-layer chromatography (TLC) using silica gel 60 F<sub>254</sub> pre-coated plates, and spots were visualized with a UV lamp or by using KMnO<sub>4</sub> or vanillin stain. Flash chromatography was performed on Silicycle 230–400 mesh silica gel. All reactions were carried out under an Ar atmosphere. Oven-dried flasks fitted with rubber septa for the introduction of substrates/reagents/solvents via syringe, and equipped with Teflon stirring bars, were employed for reactions involving air- and moisture-sensitive reagents.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Procedure for the Preparation of Pyrimidine-2,4-diamines</h3><div class="NLM_p">A mixture of an appropriate 2-aryl-3-methoxy-3-alkylacrylonitrile<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (4 mmol), guanidine hydrochloride (2 equiv), and NaHCO<sub>3</sub> (2.2 equiv) in dry DMSO (10 mL) was heated at 90 °C for <b>5h</b>. The cooled mixture was poured into EtOAc and washed sequentially with water, saturated NaHCO<sub>3</sub> solution, and brine. The organic phase was dried (MgSO<sub>4</sub>) and concentrated under reduced pressure. The crude product was purified by trituration with diethyl ether/hexanes or by recrystallization from methanol/diethyl ether. Overall yields were between 20 and 30% and were not further optimized unless the compound proved to be of interest. The following compounds were thus obtained:</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 5-(4-Chlorophenyl)-6-methylpyrimidine-2,4-diamine (<b>5a</b>)</h4><div class="NLM_p last">Known compound,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> mp >260 °C (lit.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> 264–265 °C). IR: 3471, 3306, 3091, 1624, 1553, 1477 1438, 1263, 1086. <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): 7.45 (2H, d, <i>J</i> = 8.3, ArH), 7.26 (2H, d, <i>J</i> = 8.3, ArH), 5.38 (2H, bs, NH<sub>2</sub>), 5.26 (2H, bs, NH<sub>2</sub>), 1.89 (3H, s, Me). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 162.4 (C), 162.3 (C), 162.2 (C), 135.6 (C), 132.9 (CH), 132.1 (C), 129.3 (CH), 106.2 (C), 22.4 (Me). APCI-MS: 235.3 [M<sup>35</sup>Cl+H]<sup>+</sup> (100%) and 237.2 [M<sup>37</sup>Cl+H]<sup>+</sup> (35%).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 5-(4-Chlorophenyl)-6-propylpyrimidine-2,4-diamine (<b>5b</b>)</h4><div class="NLM_p last">Known compound,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> mp 173–175 °C (lit.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> 171–174 °C). IR: 3456, 3309, 3162, 2965, 1627, 1549, 1428, 1401, 1273, 1088, 1000. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.44 (2H, d, <i>J</i> = 8.5, ArH), 7.18 (2H, d, <i>J</i> = 8.5, ArH), 5.18 (2H, bs, NH<sub>2</sub>), 4.61 (2H, bs, NH<sub>2</sub>), 2.26 (2H, t, <i>J</i> = 7.8, C<u class="uu">H</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>Me), 1.55 (2H, sex, <i>J</i> = 7.8, CH<sub>2</sub>C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 0.81 (3H, t, <i>J</i> = 7.4, CH<sub>2</sub>CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 165.2 (C), 162.14 (C), 162.11 (C), 135.2 (C), 132.8 (CH), 131.9 (C), 129.0 (CH), 105.9 (C), 36.2 (CH<sub>2</sub>), 21.6 (CH<sub>2</sub>), 14.1 (Me). ESI-MS: 263.2 [M<sup>35</sup>Cl+H] (100%) and 265.1 [M<sup>35</sup>Cl+H]<sup>+</sup> (35%).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 5-(4-Chlorophenyl)-6-isopropylpyrimidine-2,4-diamine (<b>5c</b>)</h4><div class="NLM_p last">Mp 240–242 °C. IR: 3440, 3317, 3126, 2967, 1628, 1549, 1425, 1275, 1248, 1086. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.43 (2H, d, <i>J</i> = 8.4, ArH), 7.18 (2H, d, <i>J</i> = 8.4, ArH), 4.74 (2H, bs, NH<sub>2</sub>), 4.40 (2H, bs, NH<sub>2</sub>), 2.63 (1H, sept, <i>J</i> = 6.7, C<u class="uu">H</u>(Me)<sub>2</sub>, 1.07 (6H, d, <i>J</i> = 6.7, CH(<u class="uu">Me</u>)<sub>2</sub>. <sup>13</sup>C NMR (CDCl<sub>3</sub>): 172.2 (C), 162.1 (C), 161.9 (C), 134.0 (C), 133.8 (C), 132.0 (CH), 129.5 (CH), 106.6 (C), 31.1 (CH), 21.4 (Me). APCI-MS: 263.4 [M<sup>35</sup>Cl+H]<sup>+</sup> (100%) and 265.3 [M<sup>35</sup>Cl+H]<sup>+</sup> (35%). ESI-HRMS: calcd for C<sub>13</sub>H<sub>16</sub>N<sub>4</sub><sup>35</sup>Cl [M+H]<sup>+</sup> 263.1063; found 263.1061.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5-(4-Chlorophenyl)-6-butylpyrimidine-2,4-diamine (<b>5d</b>)</h4><div class="NLM_p last">Known compound,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> mp 204–207 °C (lit.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> 208–210 °C). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 7.45 (2H, app d, J = 8.3, ArH), 7.16 (2H, app d, J = 8.3, ArH), 5.98 (2H, bs, NH<sub>2</sub>), 5.70 (2H, bs, NH<sub>2</sub>), 2.10–2.05 (2H, cm, Ar-<u class="uu">CH</u><sub><u class="uu">2</u></sub>(CH<sub>2</sub>)<sub>2</sub>CH<sub>3</sub>), 1.39 (2H, quintet, J = 7.4, Ar-CH<sub>2</sub><u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>2</sub>CH<sub>3</sub>), 1.10 (2H, sextet, J = 7.4, Ar(CH<sub>2</sub>)<sub>2</sub><u class="uu">CH</u><sub><u class="uu">2</u></sub>CH<sub>3</sub>), 0.70 (3H, t, J = 7.4, Ar(CH<sub>2</sub>)<sub>3</sub><u class="uu">CH</u><sub><u class="uu">3</u></sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 165.0 (C), 162.6 (C), 162.0 (C), 135.2 (C), 133.1 (CH), 132.3 (C), 129.3 (CH), 106.3 (C), 33.9 (CH<sub>2</sub>), 30.8 (CH<sub>2</sub>), 22.4 (CH<sub>2</sub>), 14.1 (Me).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 6-(Aminomethyl)-5-(4-chlorophenyl)pyrimidine-2,4-diamine (<b>5e</b>)</h4><div class="NLM_p">Treatment of 5-(4-chlorophenyl)-6-benzyloxymethyl-pyrimidine-2,4-diamine (prepared by the general procedure above from benzyloxyacetyl chloride and 2-(4-chlorophenyl)acetonitrile) with 45% HBr in AcOH<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> afforded 5-(4-chlorophenyl)-6-bromomethyl-pyrimidine-2,4-diamine, which was purified by trituration with ether. A portion of this material (32 mg, 102 mmol) was reacted with NaN<sub>3</sub> (66 mg, 1.02 mmol, 10 equiv) in DMSO (5 mL, rt, 12 h). The customary aqueous extractive workup afforded a solid, which was triturated with ether to afford 11 mg (30%) of pure <b>5e</b>, mp 155–158 °C. IR: 3459, 3320, 3168, 2922, 2101, 1623, 1551, 1435, 1260, 1089, 1009. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.45 (2H, d, <i>J</i> = 8.0, ArH), 7.20 (2H, d, <i>J</i> = 8.0, ArH), 5.0 (2H, bs, NH<sub>2</sub>), 4.73 (2H, bs, NH<sub>2</sub>), 3.88 (2H, s, CH<sub>2</sub>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 162.5 (C), 161.9 (C), 160.1 (C), 134.6 (C), 133.9 (C), 131.8 (CH), 129.8 (CH), 107.7 (C), 52.1 (CH<sub>2</sub>). APCI-MS: 276.4 [M<sup>35</sup>Cl+H]<sup>+</sup> (100%) and 278.3 [M<sup>37</sup>Cl+H]<sup>+</sup> (30%). ESI-HRMS: calcd for C<sub>11</sub>H<sub>11</sub>N<sub>7</sub><sup>35</sup>Cl [M+H]<sup>+</sup> 276.0764; found 276.0764. </div><div class="NLM_p last">Zinc dust (78 mg, 1.2 mmol) was added to a solution of the above azido compound (11 mg, 40 mmol) in THF/NH<sub>4</sub>Cl<sub>(aq)</sub> (2 mL, 1:1) and stirred at rt for 1 h. The solution was filtered through Celite, diluted with water, and extracted with ethyl acetate. The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated under reduced pressure. The crude residue was triturated with chloroform to the give the product as a colorless solid (10 mg, 100%), mp 171–174 °C. IR: 3331, 3206, 2920, 1612, 1546, 1455, 1348, 1257, 1088, 1007.<sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>): 7.55 (2H, d, <i>J</i> = 8.2, ArH), 7.43 (2H, d, <i>J</i> = 8.2, ArH), 6.14 (2H, bs, NH<sub>2</sub>), 4.35 (2H, s, CH<sub>2</sub>). <sup>13</sup>C NMR (acetone-<i>d</i><sub>6</sub>): 163.8 (C), 160.5 (C), 157.3 (C), 134.0 (C), 132.4 (CH), 131.2 (C), 129.8 (CH), 105.8 (C), 51.3 (CH<sub>2</sub>). APCI-MS 250.5 [M<sup>35</sup>Cl+H]<sup>+</sup> (100%) and 252.4 [M<sup>37</sup>Cl+H]<sup>+</sup> (100%). ESI-HRMS: calcd for C<sub>11</sub>H<sub>13</sub>N<sub>5</sub><sup>35</sup>Cl [M+H]<sup>+</sup> 250.0859; found 250.0858.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-Ethyl-5-(4-(methoxyphenyl)pyrimidine-2,4-diamine (<b>5f</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 7.49 (2H, d, <i>J</i> = 8.4, ArH), 6.98 (2H, d, <i>J</i> = 8.4, ArH), 5.81 (2H, bs, NH<sub>2</sub>), 5.40 (2H, bs, NH<sub>2</sub>), 3.78 (3H, s, OCH<sub>3</sub>), 2.10 (2H, q, <i>J</i> = 7.0, CH<sub>2</sub>), 0.95 (3H, t, <i>J</i> = 7.0, CH<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 167.1 (C), 162.8 (C), 162.4 (C), 158.7 (C), 132.1 (CH), 128.2 (C), 114.8 (CH), 108.5 (C), 55.4 (CH<sub>3</sub>), 27.9 (CH), 13.6 (Me).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-Ethyl-5-(4-(trifluoromethyl)phenyl)pyrimidine-2,4-diamine (<b>5g</b>)</h4><div class="NLM_p last">Known compound,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> mp 194–197 °C (lit.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> mp not given). IR: 3499, 3316, 3167, 1625, 1554, 1441, 1314, 1123, 1101, 1013; <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.71 (2H, d, <i>J</i> = 8.0, ArH), 7.39 (2H, d, <i>J</i> = 8.0, ArH), 4.99 (2H, bs, NH<sub>2</sub>), 4.58 (2H, bs, NH<sub>2</sub>), 2.26 (2H, q, <i>J</i> = 7.6, C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 1.07 (3H, t, <i>J</i> = 7.6, CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 168.6 (C), 162.0 (C), 161.8 (C), 139.5 (C), 131.1 (CH), 130.0 (q, <i>J</i><sub><i>C–F</i></sub> = 32.7, C), 126.2 (q, <i>J</i><sub>C–F</sub> = 3.7, CH), 124.0 (q, <i>J</i><sub>C–F</sub> = 272.1, CF<sub>3</sub>), 107.1 (C), 28.2 (CH<sub>2</sub>), 13.3 (Me). APCI-MS: 283.4 [M+H]<sup>+</sup> (100%).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 6-Ethyl-5-phenylpyrimidine-2,4-diamine (<b>5h</b>)</h4><div class="NLM_p last">Known compound,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> optimized yield 86%, mp 242–244 °C (lit.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> 237–240 °C). IR: 3423, 3301, 3152, 2980, 1628, 1556, 1430, 1273, 1230, 1069. <sup>1</sup>H NMR (CDCl<sub>3</sub>): 7.48–7.23 (5H, m, ArH), 4.70 (2H, bs, NH<sub>2</sub>), 4.45 (2H, bs, NH<sub>2</sub>), 2.30 (2H, q, <i>J</i> = 7.6, C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 1.07 (3H, t, <i>J</i> = 7.6, CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 166.9 (C), 162.5 (C), 136.4 (C), 131.0 (CH), 129.4 (CH), 127.6 (CH), 107.0 (C), 27.9 (CH<sub>2</sub>), 13.6 (Me). ESI-MS: 215.4 (M+H, 100%).</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-Ethyl-5-(<i>p</i>-tolyl)pyrimidine-2,4-diamine (<b>5i</b>)</h4><div class="NLM_p last">Mp 212–215 °C. IR: 3305, 1627, 1567, 1233. <sup>1</sup>H NMR (DMSO): 7.24 (d, 2H, <i>J</i> = 7.9 Hz), 7.06 (d, 2H, <i>J</i> = 7.9 Hz), 6.25 (s, 2H), 5.90 (b.s, 2H), 2.33 (s, 3H), 2.11 (q, 2H, <i>J</i> = 7.6 Hz), 0.96 (t, 3H, <i>J</i> = 7.6 Hz). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 168.0, 162.4, 161.3, 137.6, 130.3, 129.9, 108.3, 28.0, 21.2, 13.4. LRMS: 229.4 [M+H<sup>+</sup>]. HRMS: calcd for C<sub>13</sub>H<sub>17</sub>N<sub>4</sub> 229.1453; found [M+H<sup>+</sup>].</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 6-Ethyl-5-(<i>m</i>-tolyl)pyrimidine-2,4-diamine (<b>5j</b>)</h4><div class="NLM_p last">Mp 200–202 °C. IR: 3423, 3302, 3144, 2974, 1624, 1556, 1433, 1280, 1232, 1124, 1002. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) 7.30 (1H, t, <i>J</i> = 7.6, ArH), 7.13 (1H, d, <i>J</i> = 7.6, ArH), 6.98 (1H, s, ArH), 6.95 (1H, d, <i>J</i> = 7.6, ArH), 5.82 (2H, bs, NH<sub>2</sub>), 5.39 (2H, bs, NH<sub>2</sub>), 2.31 (3H, s, Me), 2.09 (2H, q, <i>J</i> = 7.5, C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 0.94 (3H, t, <i>J</i> = 7.5, CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 168.4 (C), 162.2 (C), 161.7 (C), 138.9 (C), 135.2 (C), 131.1 (CH), 129.0 (CH), 128.5 (CH), 127.5 (CH), 108.6 (C), 28.2 (CH<sub>2</sub>), 21.4 (Me), 13.4 (Me). APCI-MS: 229.3 [M+H]<sup>+</sup> (100%). ESI-HRMS: calcd for C<sub>13</sub>H<sub>17</sub>N<sub>4</sub> [M+H]<sup>+</sup> 229.1453; found 229.1451.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-Ethyl-5-(<i>o</i>-tolyl)pyrimidine-2,4-diamine (<b>5k</b>)</h4><div class="NLM_p last">Mp 174–176 °C. IR: 3439, 3311, 3175, 2977, 1624, 1549, 1428, 1267, 1113, 984. <sup>1</sup>H NMR (CDCl<sub>3</sub>) 7.31–7.29 (3H, m, ArH), 7.13 (1H, d, <i>J</i> 8.1, ArH), 4.70 (2H, bs, NH<sub>2</sub>), 4.34 (2H, bs, NH<sub>2</sub>), 2.20 (2H, q, <i>J</i> = 7.6, C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 2.14 (3H, s, Me), 1.04 (3H, t, <i>J</i> = 7.6, CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 168.4 (C), 161.89 (C), 161.86 (C), 137.9 (C), 134.2 (C), 131.0 (CH), 130.6 (CH), 128.3 (CH), 126.6 (CH), 107.4 (C), 28.1 (CH<sub>2</sub>), 19.5 (Me), 12.8 (Me). APCI-MS: 229.4 [M+H]<sup>+</sup> (100%). ESI-HRMS: calcd for C<sub>13</sub>H<sub>17</sub>N<sub>4</sub> [M+H]<sup>+</sup> 229.1453; found 229.1455.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-(3,5-Dimethylphenyl)-6-ethylpyrimidine-2,4-diamine (<b>5l</b>)</h4><div class="NLM_p last">Mp 223–225 °C. IR: 3405, 3310, 3169, 2971, 2922, 1600, 1553, 1430, 1276, 1003. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 6.94 (1H, s, ArH), 6.75 (2H, s, ArH), 5.79 (2H, bs, NH<sub>2</sub>), 5.34 (2H, bs, NH<sub>2</sub>), 2.27 (3H, s, Me), 2.09 (2H, q, <i>J</i> = 7.5, C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 0.94 (3H, t, <i>J</i> = 7.5, CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 168.3 (C), 162.3 (C), 161.6 (C), 138.7 (C), 135.1 (C), 129.3 (CH), 128.1 (CH), 108.7 (C), 28.1 (CH<sub>2</sub>), 21.3 (Me), 13.4 (Me). APCI-MS: 243.4 [M+H]<sup>+</sup> (100%). ESI-HRMS: calcd for C<sub>14</sub>H<sub>19</sub>N<sub>4</sub> [M+H]<sup>+</sup> 243.1610; found 243.1606.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Amino-6-ethyl-5-(4-chlorophenyl)pyrimidin-4(3<i>H</i>)-one (<b>6</b>)</h4><div class="NLM_p last">Known compound prepared as described by Trattner et al. in 1964.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> This material was not purified and was advanced to <b>8</b> in crude form (<85% purity). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 7.77 (d, 2H, J = 8.2 Hz, ArH), 7.44 (d, 2H, J = 8.2 Hz, ArH), 7.0 (br s, 1H, NH), 5.8 (br s, 1H, NH), 3.35 (br s, 1H, NH), 2.04 (q, 2H, <i>J</i> = 7.5 Hz, CH<sub>2</sub>), 1.02 (t, 3H, <i>J</i> = 7.5 Hz, CH<sub>3</sub>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 165.4 (C), 157.1 (C), 156.1 (C), 138.3 (C), 132.3 (CH), 126.3 (CH), 122.9 (C), 103.2 (C), 23.7 (CH<sub>2</sub>), 13.4 (CH<sub>3</sub>).</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Amino-6-ethyl-5-(4-(trifluoromethyl)phenyl)pyrimidin-4(3<i>H</i>)-one (<b>7</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 7.68 (d, 2H, <i>J</i> = 8.0 Hz), 7.39 (d, 2H, <i>J</i> = 8.0 Hz), 6.67 (bs, 2H), 2.17 (q, 2H, <i>J</i> = 7.4 Hz), 1.02 (t, 3H, <i>J</i> = 7.4 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 162.7 (C), 155.0 (C), 140.6 (C), 132.0 (CH), 127.5 (q, <i>J</i><sub>C–F</sub> = 32 Hz, C), 126.7 (CH), 125.0 (q, <i>J</i><sub>C–F</sub> = 3.8 Hz, CH), 124.8 (q, <i>J</i><sub>C–F</sub> = 273 Hz, CF<sub>3</sub>), 112.3 (C), 28.2 (CH<sub>2</sub>), 13.3 (CH<sub>3</sub>). IR: 3326, 3125, 1657, 1323. LRMS: [M+H<sup>+</sup>] 284.4. HRMS: calcd for 284.1011 C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>3</sub>O; found 284.1021 [M+H<sup>+</sup>].</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Amino-4-ethyl-5-(4-chlorophenyl)pyrimidine (<b>8</b>)</h4><div class="NLM_p last">Known compound prepared as described by Russell et al. in 1954.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.52 (s, 1H, Pyr-H), 7.49 (d, 2H, <i>J</i> = 8.1 Hz, ArH), 7.22 (d, 2H, <i>J</i> = 8.1 Hz, ArH), 4.79 (bs, 2H, NH<sub>2</sub>), 2.41 (q, 2H, <i>J</i> = 7.5, C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 1.20 (t, 3H, <i>J</i> = 7.6, CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (CDCl<sub>3</sub>): 167.3 (C), 161.0 (C), 157.4 (C), 134.5 (C), 132.6 (C), 131.0 (CH), 129.9 (CH), 115.6 (C), 28.1 (CH<sub>2</sub>), 13.3 (CH<sub>3</sub>).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Amino-4-ethyl-5-(4-(trifluoromethyl)phenyl)pyrimidine (<b>9</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (CDCl<sub>3</sub>): 8.20 (s, 1H, Pyr-H), 7.74 (d, 2H, <i>J</i> = 8.0, ArH), 7.40 (d, 2H, <i>J</i> = 8.0, ArH), 6.35 (bs, 2H, NH<sub>2</sub>) 2.72 (q, 2H, <i>J</i> = 7.5, C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 1.27 (t, 3H, <i>J</i> = 7.6, CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 170.0 (C), 159.0 (C), 156.7 (C), 138.2 (C), 130.6 (q, <i>J</i> = 32 Hz, C), 129.7 (CH), 126.0 (q, <i>J</i> = 3.7 Hz, CH), 123.8 (q, <i>J</i> =  272 Hz, CF<sub>3</sub>), 123.6 (C), 27.6 (CH<sub>2</sub>), 12.7 (CH<sub>3</sub>). IR: 3328, 3184, 1322. LRMS: 268.4 [M+H<sup>+</sup>]. HRMS: calcd for C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>3</sub> [M+H<sup>+</sup>] 268.1056; found 268.1062 [M+H<sup>+</sup>].</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 4-Amino-6-ethyl-5-(4-(trifluoromethyl)phenyl)pyrimidin-2(<i>1H</i>)-one (<b>10</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 7.77 (d, 2H, <i>J</i> = 8.0 Hz), 7.43 (d, 2H, <i>J</i> = 8.0 Hz), 7.06 (bs, 1H), 5.85 (bs, 1H), 2.03 (q, 2H, <i>J</i> = 7.6 Hz), 0.94 (t, 3H, <i>J</i> = 7.4 Hz). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 165.2, 156.8, 156.2, 138.1, 132.3, 128.6 (q, <i>J</i><sub>C–F</sub> = 32 Hz, C), 126.3 (q, <i>J</i><sub>C–F</sub> = 3.8 Hz, CH), 124.8 (<i>J</i><sub>C–F</sub> = 273.1 Hz, CF<sub>3</sub>), 103.2, 23.8 (CH<sub>2</sub>), 13.4 (CH<sub>3</sub>). IR: 3393, 1619, 1324. LRMS: 284.4 [M+H<sup>+</sup>]. HRMS: calcd for C<sub>13</sub>H<sub>13</sub>F<sub>3</sub>N<sub>3</sub>O [M+H<sup>+</sup>] 284.1011; found 284.1013.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 4-Ethyl-5-(4-(trifluoromethyl)phenyl)pyrimidine (<b>11</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): 9.16 (1H, s, Pyr-H), 8.63 (1H, s, Pyr-H), 7.88 (2H, app d, <i>J</i> = 8.0, ArH), 7.69 (2H, app d, <i>J</i> = 8.0, ArH), 2.71 (2H, q, <i>J</i> = 7.5, C<u class="uu">H</u><sub><u class="uu">2</u></sub>Me), 1.15 (3H, t, <i>J</i> = 7.5, CH<sub>2</sub><u class="uu">Me</u>). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>): 167.9 (C), 157.7 (C), 156.3 (C), 139.8 (C), 132.8 (C), 130.2 (CH), 128.8 (q, <i>J</i><sub>C–F</sub> = 32.0, C), 125.6 (q, <i>J</i><sub>C–F</sub> = 3.7, CH), 124.3 (q, <i>J</i><sub>C–F</sub> = 272.9, CF<sub>3</sub>), 27.6 (CH<sub>2</sub>), 12.3 (CH<sub>3</sub>). IR: 3060, 2929, 2856, 1324 (v. strong). ESI-MS: 253 [M+H]<sup>+</sup> (100%). ESI-HRMS: calcd for C<sub>13</sub>H<sub>12</sub>N<sub>2</sub>F<sub>3</sub> [M+H]<sup>+</sup> 253.0953; found 253.0954.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Monitoring Inhibitory Activity of PYR Derivatives against Hex A and Other Enzymes</h3><div class="NLM_p last">All test compounds were dissolved in DMSO. For enzyme reactions, the compounds were diluted such that the concentration of the diluent was 1% DMSO. Inhibitory activity of the compounds was monitored using purified human Hex A isozyme isolated from human placenta,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> together with the artificial substrate pNPGlcNAc. Enzyme reactions were performed at 37 °C in McIlvaine citrate phosphate buffer pH 4.5, containing 0.025% human serum albumin, using 10 ng/mL of human Hex A, one of the diluted compounds, and 1.6 mM colorimetric substrate pNPGlcNAc. Reactions were stopped with 0.1 M 2-amino-2-methyl-1 propanol (MAP) pH 10.5, and the absorbance was read in a Molecular Devices M2 spectrofluorometer with absorbance set to 405 nm. IC<sub>50</sub> values were extracted from the dose–response curve following non-linear curve fitting according to a built-in function within Prism Graphpad 5.0. Analysis of the inhibitory activity of compounds against mutant or wild-type human Hex A or wild-type human Hex B was performed using the Hex isozymes isolated and enriched from the lysates of either unaffected or ATSD patient fibroblasts by DEAE ion exchange chromatography. Alternatively, affinity-purified Hex B or Hex A from human placenta was used for the assay.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> IC<sub>50</sub> values comparing the inhibitory activity of PYR versus its derivatives for the different mutant or wild-type Hex isozymes were determined and analyzed as described above, except that the fluorescent substrate 4-methylumbelliferyl-2-acetamido-2-deoxy-β-<span class="smallcaps smallerCapital">d</span>-glucopyranoside (MUG, 1.6 mM), which is recognized by both the α- and β-active sites of the Hex isozymes, was used. Evaluation of the inhibitory activity of the compounds at neutral pH was performed as described above, except that pH 7 McIlvaine buffer was utilized. Inhibition studies requiring human DHFR were performed using bacterially expressed and purified human DHFR, supplied as a kit from Sigma-Aldrich (USA). Inhibition studies of purified human O-GlcNAcase by PYR were performed in the laboratory of Dr. David Vocadlo at Simon Fraser University (Burnaby, British Columbia, Canada) as described previously.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Evaluating Intracellular Hex A Activity in Treated Patient Fibroblasts</h3><div class="NLM_p last">The chaperoning efficacy of each PYR derivative, i.e., the maximum level of increase in mutant Hex A activity in treated versus non-treated fibroblasts from an ATSD patient, homozygous for the G269S mutation in the Hex α-subunit, was determined for each test compound. G269S cells were plated at 70–90% confluence (10 000–20 000 cells) in 96-well plates. Patient cells were treated for 5 days in the growth media (DMEM media supplemented with 10% fetal bovine serum) containing each of the PYR derivatives, serially diluted. DMSO levels were maintained at 1%. Subsequently, the media containing compounds were completely aspirated, and cells were washed twice with PBS prior to lysis of cells in McIlvaine buffer (pH 4.5), containing 0.4% Triton X-100 and 0.025% human serum albumin at 4 °C for 30 min. Aliquots of the crude lysates were used to measure Hex A and β-galactosidase activity utilizing the fluorogenic substrates, i.e., MU-2-acetamido-2-deoxy-β-<span class="smallcaps smallerCapital">d</span>-glucopyranoside-6-sulfate (MUGS, 1.6 mM), which is hydrolyzed primarily by the α-active site of Hex A, and MU-β-galactopyranoside (0.45 mM), respectively. Enzyme reactions were performed at 37 °C for 1–2 h and subsequently terminated using 0.1 M MAP (pH 10.5) followed by fluorescence measurement (Ex = 365 nm and Em = 450 nm) on a Molecular Devices M2 spectrofluorometer. Intracellular enzyme activity levels were expressed relative to mock (1% DMSO) treated cells, where 1 = no change. All treatments were performed in triplicate.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Western Blotting and Immunofluorescence Imaging of Treated Patient Fibroblasts</h3><div class="NLM_p last">Both methodologies were as previously described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> For immunofluorescence, fibroblasts were first fixed with 2.5% paraformaldehyde in PBS, permeabilized with 0.5% saponin, and blocked with 10% normal goat serum. The cells were then probed with a proprietary Hex A rabbit antibody, which was pre-absorbed with purified human Hex B to produce an α-specific antibody, and a LAMP1 mouse antibody (from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biological Sciences, Iowa City, IA 52242). Primary antibody binding was visualized using the corresponding secondary antibodies Alexa Fluor 488 anti-rabbit IgG (green) and Alexa Fluor 594 anti-mouse IgG (red) (Invitrogen) in the blocking solution.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Intracellular Hydrolysis of Fluorescent Analogues of GM2 Ganglioside</h3><div class="NLM_p last">Intracellular hydrolysis of GM2 ganglioside was monitored using a fluorescent analogue of GM2 ganglioside (kindly provided by W. Wakarchuk, U. Ryerson, Toronto, Canada) as previously described.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> ATSD patient fibroblasts (three confluent 10 cm plates) were treated with either PYR or one of its derivatives for 10 days. Prior to evaluation of the GM2 hydrolysis of the cell’s endogenous mutant lysosomal Hex A, the cells were treated with conduritol β-epoxide (CBE, an irreversible glucocerebrosidase inhibitor) to limit hydrolysis beyond GlcCer and loaded with a fluorescent derivative of GM2 ganglioside for 8 h. Neutral glycolipids and gangliosides were separated by Folch extraction<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> of the treated cells and divided into two pools consisting of gangliosides in the aqueous layer and neutral glycolipids in the organic layer. Gangliosides and glycolipids were resolved by high-performance thin-layer chromatography and visualized/quantified by fluorescence imaging (Storm Imager, Molecular Devices).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/jm5017895">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84137" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84137" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Figure S1, comparison of <i>in cellulo</i> enhancement of wild-type Hex A enzyme activity in fibroblasts treated with either DMSO, PYR, or <b>5h</b> (<i>n</i> = 4); spectral data and NMR spectra for representative compounds. The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/jm5017895" class="ext-link">10.1021/jm5017895</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5017895/suppl_file/jm5017895_si_001.pdf">jm5017895_si_001.pdf (1.41 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm5017895" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30136" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30136" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Don J. Mahuran</span> - <span class="hlFld-Affiliation affiliation">Genetics
and Genome Biology, SickKids, PGCRL 686 Bay Street, Toronto, Ontario M5G 0A4, Canada</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Laboratory Medicine and Pathology, University
of Toronto, Medical Science
Building, 1 King’s College Circle, 6th Floor, Toronto, Ontario M5S 1A8, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#08606d70487b616b6363616c7b266b69"><span class="__cf_email__" data-cfemail="d1b9b4a991a2b8b2babab8b5a2ffb2b0">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael B. Tropak</span> - <span class="hlFld-Affiliation affiliation">Genetics
and Genome Biology, SickKids, PGCRL 686 Bay Street, Toronto, Ontario M5G 0A4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianmin Zhang</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of British Columbia, 2036 Main Mall Vancouver, British Columbia V6T 1Z1, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sayuri Yonekawa</span> - <span class="hlFld-Affiliation affiliation">Genetics
and Genome Biology, SickKids, PGCRL 686 Bay Street, Toronto, Ontario M5G 0A4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brigitte A. Rigat</span> - <span class="hlFld-Affiliation affiliation">Genetics
and Genome Biology, SickKids, PGCRL 686 Bay Street, Toronto, Ontario M5G 0A4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Virender S. Aulakh</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of British Columbia, 2036 Main Mall Vancouver, British Columbia V6T 1Z1, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew R. Smith</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of British Columbia, 2036 Main Mall Vancouver, British Columbia V6T 1Z1, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hee-Jong Hwang</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of British Columbia, 2036 Main Mall Vancouver, British Columbia V6T 1Z1, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco A. Ciufolini</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, University of British Columbia, 2036 Main Mall Vancouver, British Columbia V6T 1Z1, Canada</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d4000e3192-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Funds from CIHR “Team” grant (CTP-82944; M.C., M.B.T and D.M.) were used to support the research presented in the manuscript along with a kind donation from the Uger estate (D.M.). We are grateful for the fluorescent GM2 ganglioside derivative kindly synthesized by Warren Wakarchuk (Ryerson University, Ontario, CAN). We thank Kam S. Ho for helping with the preparations of compounds <b>5h</b>–<b>5l</b>. We also thank Dr. Brian Mark (University of Manitoba, Manitoba, CAN) for his helpful discussions and suggestions, particularly with regard to Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> ABBREVIATIONS USED</h2><tr><td class="NLM_term">PC</td><td class="NLM_def"><p class="first last">pharmacological chaperone</p></td></tr><tr><td class="NLM_term">MU</td><td class="NLM_def"><p class="first last">4-methylumbelliferyl</p></td></tr><tr><td class="NLM_term">PYR</td><td class="NLM_def"><p class="first last">pyrimethamine</p></td></tr><tr><td class="NLM_term">ATSD</td><td class="NLM_def"><p class="first last">adult-onset Tay-Sachs disease</p></td></tr><tr><td class="NLM_term">ASD</td><td class="NLM_def"><p class="first last">adult-onset Sandhoff disease</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kongsaeree, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khongsuk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leartsakulpanich, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitnumsub, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarnchompoo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuthavong, Y.</span><span> </span><span class="NLM_article-title">Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">13046</span><span class="NLM_x">–</span> <span class="NLM_lpage">13051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13046-13051&author=P.+Kongsaereeauthor=P.+Khongsukauthor=U.+Leartsakulpanichauthor=P.+Chitnumsubauthor=B.+Tarnchompooauthor=M.+D.+Walkinshawauthor=Y.+Yuthavong&title=Crystal+structure+of+dihydrofolate+reductase+from+Plasmodium+vivax%3A+pyrimethamine+displacement+linked+with+mutation-induced+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKongsaeree%26aufirst%3DP.%26aulast%3DKhongsuk%26aufirst%3DP.%26aulast%3DLeartsakulpanich%26aufirst%3DU.%26aulast%3DChitnumsub%26aufirst%3DP.%26aulast%3DTarnchompoo%26aufirst%3DB.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DYuthavong%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520dihydrofolate%2520reductase%2520from%2520Plasmodium%2520vivax%253A%2520pyrimethamine%2520displacement%2520linked%2520with%2520mutation-induced%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D13046%26epage%3D13051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Maegawa, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kok, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span> </span><span class="NLM_article-title">Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">9150</span><span class="NLM_x">–</span> <span class="NLM_lpage">9161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=9150-9161&author=G.+H.+Maegawaauthor=M.+Tropakauthor=J.+Buttnerauthor=T.+Stockleyauthor=F.+Kokauthor=J.+T.+Clarkeauthor=D.+J.+Mahuran&title=Pyrimethamine+as+a+potential+pharmacological+chaperone+for+late-onset+forms+of+GM2+gangliosidosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaegawa%26aufirst%3DG.%2BH.%26aulast%3DTropak%26aufirst%3DM.%26aulast%3DButtner%26aufirst%3DJ.%26aulast%3DStockley%26aufirst%3DT.%26aulast%3DKok%26aufirst%3DF.%26aulast%3DClarke%26aufirst%3DJ.%2BT.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DPyrimethamine%2520as%2520a%2520potential%2520pharmacological%2520chaperone%2520for%2520late-onset%2520forms%2520of%2520GM2%2520gangliosidosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D9150%26epage%3D9161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Clarke, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolodny, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raiman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropak, M. B.</span><span> </span><span class="NLM_article-title">An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants)</span> <span class="citation_source-journal">Mol. Genet. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1016%2Fj.ymgme.2010.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=20926324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2011&pages=6-12&author=J.+T.+Clarkeauthor=D.+J.+Mahuranauthor=S.+Satheauthor=E.+H.+Kolodnyauthor=B.+A.+Rigatauthor=J.+A.+Raimanauthor=M.+B.+Tropak&title=An+open-label+Phase+I%2FII+clinical+trial+of+pyrimethamine+for+the+treatment+of+patients+affected+with+chronic+GM2+gangliosidosis+%28Tay-Sachs+or+Sandhoff+variants%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants)</span></div><div class="casAuthors">Clarke, Joe T. R.; Mahuran, Don J.; Sathe, Swati; Kolodny, Edwin H.; Rigat, Brigitte A.; Raiman, Julian A.; Tropak, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-12</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Late-onset GM2 gangliosidosis is an autosomal recessive, neurodegenerative, lysosomal storage disease, caused by deficiency of ss-hexosaminidase A (Hex A), resulting from mutations in the HEXA (Tay-Sachs variant) or the HEXB (Sandhoff variant) genes.  The enzyme deficiency in many patients with juvenile or adult onset forms of the disease results from the prodn. of an unstable protein, which becomes targeted for premature degrdn. by the quality control system of the smooth endoplasmic reticulum and is not transported to lysosomes.  In vitro studies have shown that many mutations in either the α or β subunit of Hex A can be partially rescued, i.e. enhanced levels of both enzyme protein and activity in lysosomes, following the growth of patient cells in the presence of the drug, pyrimethamine.  The objectives of the present clin. trial were to establish the tolerability and efficacy of the treatment of late-onset GM2 gangliosidosis patients with escalating doses of pyrimethamine, to a max. of 100 mg per day, administered orally in a single daily dose, over a 16-wk period .  The primary objective, tolerability, was assessed by regular clin. examns., along with a panel of hematol. and biochem. studies.  Although clin. efficacy could not be assessed in this short trial, treatment efficacy was evaluated by repeated measurements of leukocyte Hex A activity, expressed relative to the activity of lysosomal ss-glucuronidase.  A total of 11 patients were enrolled, 8 males and 3 females, aged 23 to 50 years.  One subject failed the initial screen, another was omitted from anal. because of the large no. of protocol violations, and a third was withdrawn very early as a result of adverse events which were not drug-related.  For the remaining 8 subjects, up to a 4-fold enhancement of Hex A activity at doses of 50 mg per day or less was obsd.  Addnl. marked individual variations in the pharmacokinetics of the drug among the patients were noted.  However, the study also found that significant side effects were experienced by most patients at or above 75 mg pyrimethamine per day.  We concluded that pyrimethamine treatment enhances leukocyte Hex A activity in patients with late-onset GM2 gangliosidosis at doses lower than those assocd. with unacceptable side effects.  Further plans are underway to extend these trials and to develop methods to assess clin. efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZVbvk_BJfMLVg90H21EOLACvtfcHk0lijA-NJbS3mmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFynsg%253D%253D&md5=67a35e0502c1a3a9c2fde98ebfe1aa40</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2010.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2010.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DJ.%2BT.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26aulast%3DSathe%26aufirst%3DS.%26aulast%3DKolodny%26aufirst%3DE.%2BH.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DRaiman%26aufirst%3DJ.%2BA.%26aulast%3DTropak%26aufirst%3DM.%2BB.%26atitle%3DAn%2520open-label%2520Phase%2520I%252FII%2520clinical%2520trial%2520of%2520pyrimethamine%2520for%2520the%2520treatment%2520of%2520patients%2520affected%2520with%2520chronic%2520GM2%2520gangliosidosis%2520%2528Tay-Sachs%2520or%2520Sandhoff%2520variants%2529%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2011%26volume%3D102%26spage%3D6%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Knight, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kottwitz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morant, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjoberg, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wustman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandy, S.</span><span> </span><span class="NLM_article-title">Evidence that small molecule enhancement of beta-hexosaminidase activity corrects the behavioral phenotype in Dutch APP mice through reduction of ganglioside-bound Abeta</span> <span class="citation_source-journal">Mol. Psych.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1038%2Fmp.2014.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=25349165" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=109-117&author=E.+M.+Knightauthor=H.+N.+Williamsauthor=A.+C.+Stevensauthor=S.+H.+Kimauthor=J.+C.+Kottwitzauthor=A.+D.+Morantauthor=J.+W.+Steeleauthor=W.+L.+Kleinauthor=K.+Yanagisawaauthor=R.+E.+Boydauthor=D.+J.+Lockhartauthor=E.+R.+Sjobergauthor=M.+E.+Ehrlichauthor=B.+A.+Wustmanauthor=S.+Gandy&title=Evidence+that+small+molecule+enhancement+of+beta-hexosaminidase+activity+corrects+the+behavioral+phenotype+in+Dutch+APP+mice+through+reduction+of+ganglioside-bound+Abeta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fmp.2014.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2014.135%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DE.%2BM.%26aulast%3DWilliams%26aufirst%3DH.%2BN.%26aulast%3DStevens%26aufirst%3DA.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKottwitz%26aufirst%3DJ.%2BC.%26aulast%3DMorant%26aufirst%3DA.%2BD.%26aulast%3DSteele%26aufirst%3DJ.%2BW.%26aulast%3DKlein%26aufirst%3DW.%2BL.%26aulast%3DYanagisawa%26aufirst%3DK.%26aulast%3DBoyd%26aufirst%3DR.%2BE.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DSjoberg%26aufirst%3DE.%2BR.%26aulast%3DEhrlich%26aufirst%3DM.%2BE.%26aulast%3DWustman%26aufirst%3DB.%2BA.%26aulast%3DGandy%26aufirst%3DS.%26atitle%3DEvidence%2520that%2520small%2520molecule%2520enhancement%2520of%2520beta-hexosaminidase%2520activity%2520corrects%2520the%2520behavioral%2520phenotype%2520in%2520Dutch%2520APP%2520mice%2520through%2520reduction%2520of%2520ganglioside-bound%2520Abeta%26jtitle%3DMol.%2520Psych.%26date%3D2014%26volume%3D20%26spage%3D109%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sandhoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harzer, K.</span><span> </span><span class="NLM_article-title">Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">10195</span><span class="NLM_x">–</span> <span class="NLM_lpage">10208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1523%2FJNEUROSCI.0822-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=23785136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWmsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=10195-10208&author=K.+Sandhoffauthor=K.+Harzer&title=Gangliosides+and+gangliosidoses%3A+principles+of+molecular+and+metabolic+pathogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis</span></div><div class="casAuthors">Sandhoff, Konrad; Harzer, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10195-10208</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  Gangliosides are the main glycolipids of neuronal plasma membranes.  Their surface patterns are generated by coordinated processes, involving biosynthetic pathways of the secretory compartments, catabolic steps of the endolysosomal system, and intracellular trafficking.  Inherited defects in ganglioside biosynthesis causing fatal neurodegenerative diseases have been described so far almost exclusively in mouse models, whereas inherited defects in ganglioside catabolism causing various clin. forms of GM1- and GM2-gangliosidoses have long been known.  For digestion, gangliosides are endocytosed and reach intra-endosomal vesicles.  At the level of late endosomes, they are depleted of membrane-stabilizing lipids like cholesterol and enriched with bis(monoacylglycero)phosphate (BMP).  Lysosomal catabolism is catalyzed at acidic pH values by cationic sphingolipid activator proteins (SAPs), presenting lipids to their resp. hydrolases, electrostatically attracted to the neg. charged surface of the luminal BMP-rich vesicles.  Various inherited defects of ganglioside hydrolases, e.g., of β-galactosidase and β-hexosaminidases, and of GM2-activator protein, cause infantile (with tetraparesis, dementia, blindness) and different protracted clin. forms of GM1- and GM2-gangliosidoses.  Mutations yielding proteins with small residual catabolic activities in the lysosome give rise to juvenile and adult clin. forms with a wide range of clin. symptomatol.  Apart from patients' differences in their genetic background, clin. heterogeneity may be caused by rather diverse substrate specificities and functions of lysosomal hydrolases, multifunctional properties of SAPs, and the strong regulation of ganglioside catabolism by membrane lipids.  Currently, there is no treatment available for neuronal ganglioside storage diseases.  Therapeutic approaches in mouse models and patients with juvenile forms of gangliosidoses are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6JmmE4qqeXLVg90H21EOLACvtfcHk0liClcdIjG4vlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWmsbbJ&md5=cd03f4156b362d648dd0752d067decc9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0822-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0822-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DSandhoff%26aufirst%3DK.%26aulast%3DHarzer%26aufirst%3DK.%26atitle%3DGangliosides%2520and%2520gangliosidoses%253A%2520principles%2520of%2520molecular%2520and%2520metabolic%2520pathogenesis%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D10195%26epage%3D10208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mahuran, D. J.</span><span> </span><span class="NLM_article-title">Biochemical consequences of mutations causing the GM2 gangliosidoses</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1455</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1455&publication_year=1999&pages=105-138&author=D.+J.+Mahuran&title=Biochemical+consequences+of+mutations+causing+the+GM2+gangliosidoses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DBiochemical%2520consequences%2520of%2520mutations%2520causing%2520the%2520GM2%2520gangliosidoses%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1999%26volume%3D1455%26spage%3D105%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Leinekugel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conzelmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhoff, K.</span><span> </span><span class="NLM_article-title">Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease</span> <span class="citation_source-journal">Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1007%2FBF00219337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=1348043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADyaK38XkvVOku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1992&pages=513-23&author=P.+Leinekugelauthor=S.+Michelauthor=E.+Conzelmannauthor=K.+Sandhoff&title=Quantitative+correlation+between+the+residual+activity+of+beta-hexosaminidase+A+and+arylsulfatase+A+and+the+severity+of+the+resulting+lysosomal+storage+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease</span></div><div class="casAuthors">Leinekugel, P.; Michel, S.; Conzelman, E.; Sandhoff, K.</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">513-23</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    </div><div class="casAbstract">Inherited deficiencies of the same enzyme may have quite different clin. consequences.  Lysosomal storage diseases are a particularly striking example of this general phenomenon.  The syndromes caused by allelic mutations, e.g., of a lysosomal sphingolipid hydrolase, may range from most severe infantile diseases that lead to death in early childhood, over late-infantile, juvenile and adult forms to late-adult variants with an onset of symptoms in adulthood, slow progression of the disease and almost normal life span.  Clin. healthy probands with severely reduced activity (10-20% of normal) of a lysosomal enzyme (e.g., arylsulfatase A) were also identified ("pseudodeficiency").  A previously suggested model for the correlation between residual activity of a lysosomal enzyme and the turnover rate of its substrate(s) has been extended to a discussion of substrate accumulation rates in individual cells and whole organs.  With these considerations, much of the obsd. variability in age of onset and clin. phenotype, as well as the phenomenon of pseudo-deficiency, can be understood as the consequences of small differences in the residual activity of the affected enzyme.  To exptl. verify the basic assumptions on which this model rests, studies were performed in culture.  The radiolabeled substrates ganglioside GM2 and sulfatide were added to cultures of skin fibroblasts with different activities of β-hexosaminidase A or arylsulfatase A, resp., and their uptake and turnover measured.  In both series of expts., the correlation between residual enzyme activity and the turnover rate of the substrate was essentially as predicted: degrdn. increased steeply with residual activity, to reach the control level at a residual activity of ∼10-15% of normal.  All cells with an activity above this crit. threshold had a normal turnover.  Comparison of the results of these feeding studies with the clin. status of the donor of each cell line basically confirmed these notions but also revealed the limitations of the cell culture approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNSeW2cLgCEbVg90H21EOLACvtfcHk0lgGa1gLQ1V4HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVOku70%253D&md5=437cbdfd9106018a942719a152e8bb85</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2FBF00219337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00219337%26sid%3Dliteratum%253Aachs%26aulast%3DLeinekugel%26aufirst%3DP.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DConzelmann%26aufirst%3DE.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DQuantitative%2520correlation%2520between%2520the%2520residual%2520activity%2520of%2520beta-hexosaminidase%2520A%2520and%2520arylsulfatase%2520A%2520and%2520the%2520severity%2520of%2520the%2520resulting%2520lysosomal%2520storage%2520disease%26jtitle%3DHum.%2520Genet.%26date%3D1992%26volume%3D88%26spage%3D513%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Tropak, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukovac, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakarchuk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span> </span><span class="NLM_article-title">A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates</span> <span class="citation_source-journal">Glycobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=356-65&author=M.+B.+Tropakauthor=S.+W.+Bukovacauthor=B.+A.+Rigatauthor=S.+Yonekawaauthor=W.+Wakarchukauthor=D.+J.+Mahuran&title=A+sensitive+fluorescence-based+assay+for+monitoring+GM2+ganglioside+hydrolysis+in+live+patient+cells+and+their+lysates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DBukovac%26aufirst%3DS.%2BW.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DYonekawa%26aufirst%3DS.%26aulast%3DWakarchuk%26aufirst%3DW.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DA%2520sensitive%2520fluorescence-based%2520assay%2520for%2520monitoring%2520GM2%2520ganglioside%2520hydrolysis%2520in%2520live%2520patient%2520cells%2520and%2520their%2520lysates%26jtitle%3DGlycobiology%26date%3D2010%26volume%3D20%26spage%3D356%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bateman, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherney, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span> </span><span class="NLM_article-title">Crystal structure of beta-hexosaminidase B in complex with pyrimethamine, a potential pharmacological chaperone</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1421</span><span class="NLM_x">–</span> <span class="NLM_lpage">1429</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101443u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1421-1429&author=K.+S.+Batemanauthor=M.+M.+Cherneyauthor=D.+J.+Mahuranauthor=M.+Tropakauthor=M.+N.+James&title=Crystal+structure+of+beta-hexosaminidase+B+in+complex+with+pyrimethamine%2C+a+potential+pharmacological+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm101443u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101443u%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DK.%2BS.%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26aulast%3DTropak%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DCrystal%2520structure%2520of%2520beta-hexosaminidase%2520B%2520in%2520complex%2520with%2520pyrimethamine%252C%2520a%2520potential%2520pharmacological%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1421%26epage%3D1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Tarnchompoo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirichaiwat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phupong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Intaraudom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirawaraporn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamchonwongpaisan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanichtanankul, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thebtaranonth, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuthavong, Y.</span><span> </span><span class="NLM_article-title">Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1244</span><span class="NLM_x">–</span> <span class="NLM_lpage">1252</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010131q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1244-1252&author=B.+Tarnchompooauthor=C.+Sirichaiwatauthor=W.+Phupongauthor=C.+Intaraudomauthor=W.+Sirawarapornauthor=S.+Kamchonwongpaisanauthor=J.+Vanichtanankulauthor=Y.+Thebtaranonthauthor=Y.+Yuthavong&title=Development+of+2%2C4-diaminopyrimidines+as+antimalarials+based+on+inhibition+of+the+S108N+and+C59R%2BS108N+mutants+of+dihydrofolate+reductase+from+pyrimethamine-resistant+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm010131q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010131q%26sid%3Dliteratum%253Aachs%26aulast%3DTarnchompoo%26aufirst%3DB.%26aulast%3DSirichaiwat%26aufirst%3DC.%26aulast%3DPhupong%26aufirst%3DW.%26aulast%3DIntaraudom%26aufirst%3DC.%26aulast%3DSirawaraporn%26aufirst%3DW.%26aulast%3DKamchonwongpaisan%26aufirst%3DS.%26aulast%3DVanichtanankul%26aufirst%3DJ.%26aulast%3DThebtaranonth%26aufirst%3DY.%26aulast%3DYuthavong%26aufirst%3DY.%26atitle%3DDevelopment%2520of%25202%252C4-diaminopyrimidines%2520as%2520antimalarials%2520based%2520on%2520inhibition%2520of%2520the%2520S108N%2520and%2520C59R%252BS108N%2520mutants%2520of%2520dihydrofolate%2520reductase%2520from%2520pyrimethamine-resistant%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1244%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, M. F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. P.</span><span> </span><span class="NLM_article-title">Structural studies on bio-active compounds.III. Re-examination of the hydrolysis of the antimalarial drug pyrimethamine and related derivatives and crystal-structure of a hydrolysis product</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=2267-2276&author=R.+J.+Griffinauthor=C.+H.+Schwalbeauthor=M.+F.+G.+Stevensauthor=K.+P.+Wong&title=Structural+studies+on+bio-active+compounds.III.+Re-examination+of+the+hydrolysis+of+the+antimalarial+drug+pyrimethamine+and+related+derivatives+and+crystal-structure+of+a+hydrolysis+product"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DSchwalbe%26aufirst%3DC.%2BH.%26aulast%3DStevens%26aufirst%3DM.%2BF.%2BG.%26aulast%3DWong%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520studies%2520on%2520bio-active%2520compounds.III.%2520Re-examination%2520of%2520the%2520hydrolysis%2520of%2520the%2520antimalarial%2520drug%2520pyrimethamine%2520and%2520related%2520derivatives%2520and%2520crystal-structure%2520of%2520a%2520hydrolysis%2520product%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1985%26spage%3D2267%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Mark, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherney, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span> </span><span class="NLM_article-title">Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2003&pages=1093-1109&author=B.+L.+Markauthor=D.+J.+Mahuranauthor=M.+M.+Cherneyauthor=D.+Zhaoauthor=S.+Knappauthor=M.+N.+James&title=Crystal+structure+of+human+beta-hexosaminidase+B%3A+understanding+the+molecular+basis+of+Sandhoff+and+Tay-Sachs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMark%26aufirst%3DB.%2BL.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DCrystal%2520structure%2520of%2520human%2520beta-hexosaminidase%2520B%253A%2520understanding%2520the%2520molecular%2520basis%2520of%2520Sandhoff%2520and%2520Tay-Sachs%2520disease%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D327%26spage%3D1093%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Macauley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitworth, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vocadlo, D. J.</span><span> </span><span class="NLM_article-title">O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">25313</span><span class="NLM_x">–</span> <span class="NLM_lpage">25322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1074%2Fjbc.M413819200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=15795231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslyltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25313-25322&author=M.+S.+Macauleyauthor=G.+E.+Whitworthauthor=A.+W.+Debowskiauthor=D.+Chinauthor=D.+J.+Vocadlo&title=O-GlcNAcase+uses+substrate-assisted+catalysis%3A+kinetic+analysis+and+development+of+highly+selective+mechanism-inspired+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">O-GlcNAcase Uses Substrate-assisted Catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors</span></div><div class="casAuthors">Macauley, Matthew S.; Whitworth, Garrett E.; Debowski, Aleksandra W.; Chin, Danielle; Vocadlo, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">25313-25322</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The post-translational modification of serine and threonine residues of nucleocytoplasmic proteins with 2-acetamido-2-deoxy-D-glucopyranose (GlcNAc) is a reversible process implicated in multiple cellular processes.  The enzyme O-GlcNAcase catalyzes the cleavage of β-O-linked GlcNAc (O-GlcNAc) from modified proteins and is a member of the family 84 glycoside hydrolases.  The family 20 β-hexosaminidases bear no apparent sequence similarity yet are functionally related to O-GlcNAcase because both enzymes cleave terminal GlcNAc residues from glycoconjugates.  Lysosomal β-hexosaminidase is known to use substrate-assisted catalysis involving the 2-acetamido group of the substrate; however, the catalytic mechanism of human O-GlcNAcase is unknown.  By using a series of 4-methylumbelliferyl 2-deoxy-2-N-fluoroacetyl-β-D-glucopyranoside substrates, Taft-like linear free energy analyses of these enzymes indicates that O-GlcNAcase uses a catalytic mechanism involving anchimeric assistance.  Consistent with this proposal, 1,2-dideoxy-2'-methyl-α-D-glucopyranoso-[2,1-d]-Δ2'-thiazoline, an inhibitor that mimics the oxazoline intermediate proposed in the catalytic mechanism of family 20 glycoside hydrolases, is shown to act as a potent competitive inhibitor of both O-GlcNAcase (KII = 0.070 μM) and β-hexosaminidase (K = 0.070 μM).  A series of 1,2-dideoxy-2'-methyl-α-D-glucopyranoso-[2,1-d]-Δ2'-thiazoline analogs were prepd., and one inhibitor demonstrated a remarkable 1500-fold selectivity for O-GlcNAcase (KI = 0.230 μM) over β-hexosaminidase (KI = 340 μM).  These inhibitors are cell permeable and modulate the activity of O-GlcNAcase in tissue culture.  Because both enzymes have vital roles in organismal health, these potent and selective inhibitors of O-GlcNAcase should prove useful in studying the role of this enzyme at the organismal level without generating a complex chem. phenotype stemming from concomitant inhibition of β-hexosaminidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf5bwGkGmPr7Vg90H21EOLACvtfcHk0lgHCxKyCN1KLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslyltL4%253D&md5=77ec4816fd8d52878cb8025e9b5555e6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413819200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413819200%26sid%3Dliteratum%253Aachs%26aulast%3DMacauley%26aufirst%3DM.%2BS.%26aulast%3DWhitworth%26aufirst%3DG.%2BE.%26aulast%3DDebowski%26aufirst%3DA.%2BW.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DVocadlo%26aufirst%3DD.%2BJ.%26atitle%3DO-GlcNAcase%2520uses%2520substrate-assisted%2520catalysis%253A%2520kinetic%2520analysis%2520and%2520development%2520of%2520highly%2520selective%2520mechanism-inspired%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25313%26epage%3D25322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Takakura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haque, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi-Nejad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4143</span><span class="NLM_x">–</span> <span class="NLM_lpage">4154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1093%2Fhmg%2Fddr338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=21821671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yltrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=4143-4154&author=A.+Takakuraauthor=E.+A.+Nelsonauthor=N.+Haqueauthor=B.+D.+Humphreysauthor=K.+Zandi-Nejadauthor=D.+A.+Frankauthor=J.+Zhou&title=Pyrimethamine+inhibits+adult+polycystic+kidney+disease+by+modulating+STAT+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways</span></div><div class="casAuthors">Takakura, Ayumi; Nelson, Erik A.; Haque, Nadeem; Humphreys, Benjamin D.; Zandi-Nejad, Kambiz; Frank, David A.; Zhou, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4143-4154</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Autosomal dominant polycystic kidney disease (ADPKD) is a commonly inherited disorder mostly caused by mutations in PKD1, encoding polycystin-1 (PC1).  The disease is characterized by development and growth of epithelium-lined cyst in both kidneys, often leading to renal failure.  There is no specific treatment for this disease.  Here, we report a sustained activation of the transcription factor signal transducer and activator of transcription 3 (STAT3) in ischemic injured and uninjured Pkd1 knockout polycystic kidneys and in human ADPKD kidneys.  Through a chem. library screen, we identified the anti-parasitic compd. pyrimethamine as an inhibitor of STAT3 function.  Treatment with pyrimethamine decreases cell proliferation in human ADPKD cells and blocks renal cyst formation in an adult and a neonatal PKD mouse model.  Moreover, we demonstrated that a specific STAT3 inhibitor, S3I-201, reduces cyst formation and growth in a neonatal PKD mouse model.  Our results suggest that PC1 acts as a neg. regulator of STAT3 and that blocking STAT3 signaling with pyrimethamine or similar drugs may be an attractive therapy for human ADPKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVEStaa2l9HbVg90H21EOLACvtfcHk0lgHCxKyCN1KLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yltrjP&md5=e5bae0f5d88e2e44da18b96ca0c46236</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr338%26sid%3Dliteratum%253Aachs%26aulast%3DTakakura%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DE.%2BA.%26aulast%3DHaque%26aufirst%3DN.%26aulast%3DHumphreys%26aufirst%3DB.%2BD.%26aulast%3DZandi-Nejad%26aufirst%3DK.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DPyrimethamine%2520inhibits%2520adult%2520polycystic%2520kidney%2520disease%2520by%2520modulating%2520STAT%2520signaling%2520pathways%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D4143%26epage%3D4154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Reich, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">Tracking STAT nuclear traffic</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1038%2Fnri1885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=16868551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1yisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=602-612&author=N.+C.+Reichauthor=L.+Liu&title=Tracking+STAT+nuclear+traffic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking STAT nuclear traffic</span></div><div class="casAuthors">Reich, Nancy C.; Liu, Ling</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">602-612</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Accurate cellular localization is crucial for the effective function of most signaling mols. and nuclear translocation is central to the function of transcription factors.  The passage of large mols. between the cytoplasm and nucleus is restricted, and this restriction affords a mechanism to regulate transcription by controlling the access of transcription factors to the nucleus.  Here, the authors have focused on the signal transducer and activator of transcription (STAT) family of transcription factors.  The regulation of nuclear trafficking of STAT-family members is diverse.  Some STAT proteins constitutively shuttle between the nucleus and cytoplasm, whereas others require tyrosine phosphorylation for nuclear localization.  In either case, the regulation of nuclear trafficking can provide a target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMmCEDYxf8Y7Vg90H21EOLACvtfcHk0lgHCxKyCN1KLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1yisLY%253D&md5=db8226f9ef065b39cd7708ac7db032af</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnri1885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1885%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DN.%2BC.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DTracking%2520STAT%2520nuclear%2520traffic%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2006%26volume%3D6%26spage%3D602%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Horvath, C. M.</span><span> </span><span class="NLM_article-title">STAT proteins and transcriptional responses to extracellular signals</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=496-502&author=C.+M.+Horvath&title=STAT+proteins+and+transcriptional+responses+to+extracellular+signals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorvath%26aufirst%3DC.%2BM.%26atitle%3DSTAT%2520proteins%2520and%2520transcriptional%2520responses%2520to%2520extracellular%2520signals%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2000%26volume%3D25%26spage%3D496%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Hasilik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neufeld, E. F.</span><span> </span><span class="NLM_article-title">Biosynthesis of lysosomal enzymes in fibroblasts: synthesis as precursors of higher molecular weight</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">4937</span><span class="NLM_x">–</span> <span class="NLM_lpage">4945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=4937-4945&author=A.+Hasilikauthor=E.+F.+Neufeld&title=Biosynthesis+of+lysosomal+enzymes+in+fibroblasts%3A+synthesis+as+precursors+of+higher+molecular+weight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHasilik%26aufirst%3DA.%26aulast%3DNeufeld%26aufirst%3DE.%2BF.%26atitle%3DBiosynthesis%2520of%2520lysosomal%2520enzymes%2520in%2520fibroblasts%253A%2520synthesis%2520as%2520precursors%2520of%2520higher%2520molecular%2520weight%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D4937%26epage%3D4945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Weiss, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanowitz, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittner, M.</span><span> </span><span class="NLM_article-title">Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1093%2Finfdis%2F157.3.580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=3343528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A280%3ADyaL1c7ktVCjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=1988&pages=580-583&author=L.+M.+Weissauthor=C.+Harrisauthor=M.+Bergerauthor=H.+B.+Tanowitzauthor=M.+Wittner&title=Pyrimethamine+concentrations+in+serum+and+cerebrospinal+fluid+during+treatment+of+acute+Toxoplasma+encephalitis+in+patients+with+AIDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS</span></div><div class="casAuthors">Weiss L M; Harris C; Berger M; Tanowitz H B; Wittner M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">580-3</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgCg2G22RuB0cLvDNbOD4DfW6udTcc2ebn-Mtl_0wJx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c7ktVCjug%253D%253D&md5=2b7b653b65a9a9ae825114fee39ca9b9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F157.3.580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F157.3.580%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26aulast%3DHarris%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DTanowitz%26aufirst%3DH.%2BB.%26aulast%3DWittner%26aufirst%3DM.%26atitle%3DPyrimethamine%2520concentrations%2520in%2520serum%2520and%2520cerebrospinal%2520fluid%2520during%2520treatment%2520of%2520acute%2520Toxoplasma%2520encephalitis%2520in%2520patients%2520with%2520AIDS%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1988%26volume%3D157%26spage%3D580%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2ebn-Mtl_0wJx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kofron, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baclawski, L. M.</span><span> </span><span class="NLM_article-title">Convenient method for estimation of alkyllithium concentrations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1880</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00872a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1976&pages=1879-1880&author=W.+G.+Kofronauthor=L.+M.+Baclawski&title=Convenient+method+for+estimation+of+alkyllithium+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo00872a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00872a047%26sid%3Dliteratum%253Aachs%26aulast%3DKofron%26aufirst%3DW.%2BG.%26aulast%3DBaclawski%26aufirst%3DL.%2BM.%26atitle%3DConvenient%2520method%2520for%2520estimation%2520of%2520alkyllithium%2520concentrations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1976%26volume%3D41%26spage%3D1879%26epage%3D1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Russell, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchings, G. H.</span><span> </span><span class="NLM_article-title">2,4-diaminopyrimidines as antimalarials.III. 5-aryl derivatives</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3763</span><span class="NLM_x">–</span> <span class="NLM_lpage">3770</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01152a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1951&pages=3763-3770&author=P.+B.+Russellauthor=G.+H.+Hitchings&title=2%2C4-diaminopyrimidines+as+antimalarials.III.+5-aryl+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fja01152a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01152a060%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DP.%2BB.%26aulast%3DHitchings%26aufirst%3DG.%2BH.%26atitle%3D2%252C4-diaminopyrimidines%2520as%2520antimalarials.III.%25205-aryl%2520derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1951%26volume%3D73%26spage%3D3763%26epage%3D3770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Rogers, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leanza, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarett, L. H.</span><span> </span><span class="NLM_article-title">Antiparasitic agents 0.1. Some new 2,4-diaminopyrimidines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1492</span><span class="NLM_x">–</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01362a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1957&pages=1492-1494&author=E.+F.+Rogersauthor=W.+J.+Leanzaauthor=L.+H.+Sarett&title=Antiparasitic+agents+0.1.+Some+new+2%2C4-diaminopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo01362a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01362a045%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DE.%2BF.%26aulast%3DLeanza%26aufirst%3DW.%2BJ.%26aulast%3DSarett%26aufirst%3DL.%2BH.%26atitle%3DAntiparasitic%2520agents%25200.1.%2520Some%2520new%25202%252C4-diaminopyrimidines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1957%26volume%3D22%26spage%3D1492%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosogof, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, L. T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczepankiewicz, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaszubska, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falls, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span> </span><span class="NLM_article-title">Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: Side chain exploration</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1864-1868&author=B.+Liuauthor=M.+Liuauthor=Z.+L.+Xinauthor=H.+Y.+Zhaoauthor=M.+D.+Serbyauthor=C.+Kosogofauthor=L.+T.+J.+Nelsonauthor=B.+G.+Szczepankiewiczauthor=W.+Kaszubskaauthor=V.+G.+Schaeferauthor=H.+D.+Fallsauthor=C.+W.+Linauthor=C.+A.+Collinsauthor=H.+L.+Shamauthor=G.+Liu&title=Optimization+of+2%2C4-diaminopyrimidines+as+GHS-R+antagonists%3A+Side+chain+exploration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DZ.%2BL.%26aulast%3DZhao%26aufirst%3DH.%2BY.%26aulast%3DSerby%26aufirst%3DM.%2BD.%26aulast%3DKosogof%26aufirst%3DC.%26aulast%3DNelson%26aufirst%3DL.%2BT.%2BJ.%26aulast%3DSzczepankiewicz%26aufirst%3DB.%2BG.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DSchaefer%26aufirst%3DV.%2BG.%26aulast%3DFalls%26aufirst%3DH.%2BD.%26aulast%3DLin%26aufirst%3DC.%2BW.%26aulast%3DCollins%26aufirst%3DC.%2BA.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DOptimization%2520of%25202%252C4-diaminopyrimidines%2520as%2520GHS-R%2520antagonists%253A%2520Side%2520chain%2520exploration%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1864%26epage%3D1868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Barlin, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotecka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieckmann, K. H.</span><span> </span><span class="NLM_article-title">Potential antimalarials.XXII. Some 2,4-diamino-5-(3- and 4-trifluoromethylphenyl and 3,4-methylenedioxyphenyl)pyrimidines</span> <span class="citation_source-journal">Aus. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADyaK28XltlKgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=647-650&author=G.+B.+Barlinauthor=B.+Koteckaauthor=K.+H.+Rieckmann&title=Potential+antimalarials.XXII.+Some+2%2C4-diamino-5-%283-+and+4-trifluoromethylphenyl+and+3%2C4-methylenedioxyphenyl%29pyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Potential antimalarials. XXII. Some 2,4-diamino-5-(3- and 4-trifluoromethylphenyl and 3,4-methylenedioxyphenyl)pyrimidines</span></div><div class="casAuthors">Barlin, Gordon B.; Kotecka, Barbara; Rieckmann, Karl H.</div><div class="citationInfo"><span class="NLM_cas:title">Australian Journal of Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-650</span>CODEN:
                <span class="NLM_cas:coden">AJCHAS</span>;
        ISSN:<span class="NLM_cas:issn">0004-9425</span>.
    
            (<span class="NLM_cas:orgname">Commonwealth Scientific and Industrial Research Organization</span>)
        </div><div class="casAbstract">A series of 10 pyrimethamine analogs contg. 3'- and 4'-trifluoromethyl and 3',4'-methylenedioxy groups, I (R = Et, H, Me, CF3, X = 4'-Cl, 3'-CF3, 4'-CF3, 3'4'-OCH2O), has been prepd. and tested for in vitro antimalarial activity against the FC-27 and k-1 isolates of Plasmodium falciparum.  Several of these compds. were almost as active as pyrimethamine against the drug-sensitive FC-27 isolate, and like pyrimethamine, they were much less active against the drug-resistant k-1 isolate.  The 4'-trifluoromethyl compds., however, showed much smaller differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7QAb_TwV7vLVg90H21EOLACvtfcHk0ljopswJC2yN-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlKgs70%253D&md5=c7b36bb08a27bca3e3e4670f9142f272</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarlin%26aufirst%3DG.%2BB.%26aulast%3DKotecka%26aufirst%3DB.%26aulast%3DRieckmann%26aufirst%3DK.%2BH.%26atitle%3DPotential%2520antimalarials.XXII.%2520Some%25202%252C4-diamino-5-%25283-%2520and%25204-trifluoromethylphenyl%2520and%25203%252C4-methylenedioxyphenyl%2529pyrimidines%26jtitle%3DAus.%2520J.%2520Chem.%26date%3D1996%26volume%3D49%26spage%3D647%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Trattner, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchings, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharefkin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elion, G. B.</span><span> </span><span class="NLM_article-title">Deamination studies on pyrimidine and condensed pyrimidine systems</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2677</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01032a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1964&pages=2674-2677&author=R.+B.+Trattnerauthor=G.+H.+Hitchingsauthor=D.+M.+Sharefkinauthor=G.+B.+Elion&title=Deamination+studies+on+pyrimidine+and+condensed+pyrimidine+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo01032a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01032a047%26sid%3Dliteratum%253Aachs%26aulast%3DTrattner%26aufirst%3DR.%2BB.%26aulast%3DHitchings%26aufirst%3DG.%2BH.%26aulast%3DSharefkin%26aufirst%3DD.%2BM.%26aulast%3DElion%26aufirst%3DG.%2BB.%26atitle%3DDeamination%2520studies%2520on%2520pyrimidine%2520and%2520condensed%2520pyrimidine%2520systems%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1964%26volume%3D29%26spage%3D2674%26epage%3D2677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Russell, P. B.</span><span> </span><span class="NLM_article-title">The effects of substitution on the ultra-violet absorption spectra of phenylpyrimidines</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_fpage">2951</span><span class="NLM_x">–</span> <span class="NLM_lpage">2955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1954&pages=2951-2955&author=P.+B.+Russell&title=The+effects+of+substitution+on+the+ultra-violet+absorption+spectra+of+phenylpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DP.%2BB.%26atitle%3DThe%2520effects%2520of%2520substitution%2520on%2520the%2520ultra-violet%2520absorption%2520spectra%2520of%2520phenylpyrimidines%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1954%26spage%3D2951%26epage%3D2955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Mahuran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowden, J. A.</span><span> </span><span class="NLM_article-title">The subunit and polypeptide structure of hexosaminidases from human placenta</span> <span class="citation_source-journal">Can. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1139%2Fv80-046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=7378875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADyaL3cXktVejsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1980&pages=287-294&author=D.+Mahuranauthor=J.+A.+Lowden&title=The+subunit+and+polypeptide+structure+of+hexosaminidases+from+human+placenta"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The subunit and polypeptide structure of hexosaminidases from human placenta</span></div><div class="casAuthors">Mahuran, D.; Lowden, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-94</span>CODEN:
                <span class="NLM_cas:coden">CJBIAE</span>;
        ISSN:<span class="NLM_cas:issn">0008-4018</span>.
    </div><div class="casAbstract">Hexosaminidases (HEX) are tetrameric enzymes composed of either 2 dimers of β chains (HEX B) or a β-chain dimer and an α-chain dimer (HEX A).  HEX S contains only α chains.  HEX A and B of human placenta were purified >6000-fold.  From HEX A was prepd. HEX B and a more anodically migrating HEX S.  After either extensive redn. and alkylation or performic acid oxidn., HEX B gave only a single protein band in polyacrylamide gel electrophoresis in Na dodecyl sulfate; HEX A consistently gave 2 bands indicating it contained chains of 2 different mol. wts.  To rule out hydrophobic interaction, mol. wt. was detd. by gel filtration in 6M guanidine-HCl.  Complete disulfide bond breakage was ensured by using a harsher redn. and alkylation procedure than previously employed.  The results were then confirmed by the use of 2 performic acid oxidn. techniques, the stronger method resulting in extensive peptide bond oxidn.  Samples of HEX A under redn. and alkylation or the weaker performic acid oxidn. procedure again chromatographed as 2 approx. equal peaks (50,000 and 25,000).  HEX B, and the HEX B prepd. from HEX A, resulted in one 25,000-dalton peak.  HEX S chromatographed as a single 50,000 peak.  Thus, either the α chain in HEX has a mol. wt. of 50,000 with one α chain per α subunit or 2 25,000-dalton chains are united by a nondisulfide crosslink (e.g., an isopeptide bond).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUxiiQEc2_ArVg90H21EOLACvtfcHk0lhcS-e1M-SmXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktVejsb8%253D&md5=eef1e07aecfb9284e1077d89eed06824</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1139%2Fv80-046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv80-046%26sid%3Dliteratum%253Aachs%26aulast%3DMahuran%26aufirst%3DD.%26aulast%3DLowden%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520subunit%2520and%2520polypeptide%2520structure%2520of%2520hexosaminidases%2520from%2520human%2520placenta%26jtitle%3DCan.%2520J.%2520Biochem.%26date%3D1980%26volume%3D58%26spage%3D287%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tropak, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withers, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D.</span><span> </span><span class="NLM_article-title">Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13478</span><span class="NLM_x">–</span> <span class="NLM_lpage">13487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13478-13487&author=M.+B.+Tropakauthor=S.+P.+Reidauthor=M.+Guiralauthor=S.+G.+Withersauthor=D.+Mahuran&title=Pharmacological+enhancement+of+beta-hexosaminidase+activity+in+fibroblasts+from+adult+Tay-Sachs+and+Sandhoff+Patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DReid%26aufirst%3DS.%2BP.%26aulast%3DGuiral%26aufirst%3DM.%26aulast%3DWithers%26aufirst%3DS.%2BG.%26aulast%3DMahuran%26aufirst%3DD.%26atitle%3DPharmacological%2520enhancement%2520of%2520beta-hexosaminidase%2520activity%2520in%2520fibroblasts%2520from%2520adult%2520Tay-Sachs%2520and%2520Sandhoff%2520Patients%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13478%26epage%3D13487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Tropak, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhaber, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegawa, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuske, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coales, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamuro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span> </span><span class="NLM_article-title">Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on beta-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2650</span><span class="NLM_x">–</span> <span class="NLM_lpage">2662</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2650-2662&author=M.+B.+Tropakauthor=G.+J.+Kornhaberauthor=B.+A.+Rigatauthor=G.+H.+Maegawaauthor=J.+D.+Buttnerauthor=J.+E.+Blanchardauthor=C.+Murphyauthor=S.+J.+Tuskeauthor=S.+J.+Coalesauthor=Y.+Hamuroauthor=E.+D.+Brownauthor=D.+J.+Mahuran&title=Identification+of+pharmacological+chaperones+for+Gaucher+disease+and+characterization+of+their+effects+on+beta-glucocerebrosidase+by+hydrogen%2Fdeuterium+exchange+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DKornhaber%26aufirst%3DG.%2BJ.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DMaegawa%26aufirst%3DG.%2BH.%26aulast%3DButtner%26aufirst%3DJ.%2BD.%26aulast%3DBlanchard%26aufirst%3DJ.%2BE.%26aulast%3DMurphy%26aufirst%3DC.%26aulast%3DTuske%26aufirst%3DS.%2BJ.%26aulast%3DCoales%26aufirst%3DS.%2BJ.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DE.%2BD.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520of%2520pharmacological%2520chaperones%2520for%2520Gaucher%2520disease%2520and%2520characterization%2520of%2520their%2520effects%2520on%2520beta-glucocerebrosidase%2520by%2520hydrogen%252Fdeuterium%2520exchange%2520mass%2520spectrometry%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D2650%26epage%3D2662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Lees, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S.</span><span> </span><span class="NLM_article-title">A simple procedure for the preparation of brain sulphatides</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1111%2Fj.1471-4159.1959.tb13169.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=13655088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADyaG1MXnvVajuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1959&pages=9-18&author=M.+Leesauthor=J.+Folchauthor=G.+H.+Stanleyauthor=S.+Carr&title=A+simple+procedure+for+the+preparation+of+brain+sulphatides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A simple procedure for the preparation of brain sulfatides</span></div><div class="casAuthors">Lees, M. B.; Folch-Pi, J.; Sloane Stanley, G. H.; Carr, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1959</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">No. 1</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">cf. C.A. 46, 159i.  Sulfatides from bovine brain white matter were isolated by distribution of the lipides between two phases of a series of related solvent systems.  Two main fractions were obtained; one fraction was essentially pure sulfatide (sulfatide A), the other contained both S and P and was sepd. into a P-free sulfatide fraction and a phosphatide mixt. by passage through a Florisil column.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmxInaKZTeLbVg90H21EOLACvtfcHk0lhcS-e1M-SmXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXnvVajuw%253D%253D&md5=46e3718def3885fa8502e6a238f01747</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1959.tb13169.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1959.tb13169.x%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DM.%26aulast%3DFolch%26aufirst%3DJ.%26aulast%3DStanley%26aufirst%3DG.%2BH.%26aulast%3DCarr%26aufirst%3DS.%26atitle%3DA%2520simple%2520procedure%2520for%2520the%2520preparation%2520of%2520brain%2520sulphatides%26jtitle%3DJ.%2520Neurochem.%26date%3D1959%26volume%3D4%26spage%3D9%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">João A. Baptista, Ricardo A. E. Castro, Mário T. S. Rosado, Teresa M. R. Maria, M. Ramos Silva, João Canotilho, <span class="NLM_string-name hlFld-ContribAuthor">M. Ermelinda S. Eusébio</span>. </span><span class="cited-content_cbyCitation_article-title">Polymorphic Cocrystals of the Antimalarial Drug Pyrimethamine: Two Case Studies. </span><span class="cited-content_cbyCitation_journal-name">Crystal Growth & Design</span><span> <strong>2021,</strong> <em>21 </em>
                                    (7)
                                     , 3699-3713. <a href="https://doi.org/10.1021/acs.cgd.1c00005" title="DOI URL">https://doi.org/10.1021/acs.cgd.1c00005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.cgd.1c00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.cgd.1c00005%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystal%2520Growth%2520%2526%2520Design%26atitle%3DPolymorphic%252BCocrystals%252Bof%252Bthe%252BAntimalarial%252BDrug%252BPyrimethamine%25253A%252BTwo%252BCase%252BStudies%26aulast%3DBaptista%26aufirst%3DJo%25C3%25A3o%2BA.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04012021%26date%3D14052021%26date%3D28052021%26volume%3D21%26issue%3D7%26spage%3D3699%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine H.  Schein</span>. </span><span class="cited-content_cbyCitation_article-title">Repurposing approved drugs on the pathway to novel therapies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (2)
                                     , 586-605. <a href="https://doi.org/10.1002/med.21627" title="DOI URL">https://doi.org/10.1002/med.21627</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21627%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DRepurposing%252Bapproved%252Bdrugs%252Bon%252Bthe%252Bpathway%252Bto%252Bnovel%252Btherapies%26aulast%3DSchein%26aufirst%3DCatherine%2BH.%26date%3D2020%26volume%3D40%26issue%3D2%26spage%3D586%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bocheng  Wu</span>, <span class="hlFld-ContribAuthor ">Shaghayegh  Fathi</span>, <span class="hlFld-ContribAuthor ">Shanee  Mortley</span>, <span class="hlFld-ContribAuthor ">Mahir  Mohiuddin</span>, <span class="hlFld-ContribAuthor ">Young C.  Jang</span>, <span class="hlFld-ContribAuthor ">Adegboyega K.  Oyelere</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrimethamine conjugated histone deacetylase inhibitors: Design, synthesis and evidence for triple negative breast cancer selective cytotoxicity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (6)
                                     , 115345. <a href="https://doi.org/10.1016/j.bmc.2020.115345" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115345%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DPyrimethamine%252Bconjugated%252Bhistone%252Bdeacetylase%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%252Band%252Bevidence%252Bfor%252Btriple%252Bnegative%252Bbreast%252Bcancer%252Bselective%252Bcytotoxicity%26aulast%3DWu%26aufirst%3DBocheng%26date%3D2020%26volume%3D28%26issue%3D6%26spage%3D115345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tian  Liu</span>, <span class="hlFld-ContribAuthor ">Yanwei  Duan</span>, <span class="hlFld-ContribAuthor ">Qing  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting glycoside hydrolase family 20 β-N-acetyl-d-hexosaminidases: Crystal structures, physiological substrates and specific inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Biotechnology Advances</span><span> <strong>2018,</strong> <em>36 </em>
                                    (4)
                                     , 1127-1138. <a href="https://doi.org/10.1016/j.biotechadv.2018.03.013" title="DOI URL">https://doi.org/10.1016/j.biotechadv.2018.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biotechadv.2018.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biotechadv.2018.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBiotechnology%2520Advances%26atitle%3DRevisiting%252Bglycoside%252Bhydrolase%252Bfamily%252B20%252B%2525CE%2525B2-N-acetyl-d-hexosaminidases%25253A%252BCrystal%252Bstructures%25252C%252Bphysiological%252Bsubstrates%252Band%252Bspecific%252Binhibitors%26aulast%3DLiu%26aufirst%3DTian%26date%3D2018%26volume%3D36%26issue%3D4%26spage%3D1127%26epage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chieh-Kai  Chan</span>, <span class="hlFld-ContribAuthor ">Meng-Yang  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">BF 3 ·OEt 2 -mediated [1,2]-aryl shift: Synthesis of functionalized α-arylnitriles via the bromination/cyanation/deformylation of substituted deoxybenzoin. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2017,</strong> <em>73 </em>
                                    (34)
                                     , 5207-5213. <a href="https://doi.org/10.1016/j.tet.2017.07.015" title="DOI URL">https://doi.org/10.1016/j.tet.2017.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2017.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2017.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DBF%252B3%252B%2525C2%2525B7OEt%252B2%252B-mediated%252B%25255B1%25252C2%25255D-aryl%252Bshift%25253A%252BSynthesis%252Bof%252Bfunctionalized%252B%2525CE%2525B1-arylnitriles%252Bvia%252Bthe%252Bbromination%25252Fcyanation%25252Fdeformylation%252Bof%252Bsubstituted%252Bdeoxybenzoin%26aulast%3DChan%26aufirst%3DChieh-Kai%26date%3D2017%26volume%3D73%26issue%3D34%26spage%3D5207%26epage%3D5213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. Alison  Rinderspacher</span>. </span><span class="cited-content_cbyCitation_article-title">Six-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 439-492. <a href="https://doi.org/10.1016/B978-0-08-100755-6.00013-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-100755-6.00013-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100755-6.00013-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100755-6.00013-2%26sid%3Dliteratum%253Aachs%26atitle%3DSix-Membered%252BRing%252BSystems%26aulast%3DRinderspacher%26aufirst%3DK.%2BAlison%26date%3D2016%26spage%3D439%26epage%3D492%26pub%3DElsevier%26date%3D2016%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Structure of pyrimethamine (PYR). (B) Amino acid residues (green) in the active site involved in binding PYR (yellow). The chlorine atom on PYR is highlighted in red. Residues participating in formation of the active site from the adjacent subunit are shown in marine blue. Amino acid residues (D290, D240, E491) directly forming hydrogen bonds (denoted with dashed blue lines) with the amino (blue) groups on PYR are highlighted in green. The ethyl group of PYR is found in a hydrophobic pocket formed by residues W405 and W424 (green).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Procedure for Synthesis of PYR Analogues and Representative Compounds Examined in This Study</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Des-amino Analogues of <b>1</b> and <b>5g</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Comparison of the toxicity of PYR and <b>5h</b> in patient fibroblasts and their respective <i>in vitro</i> inhibitory activity against human DHFR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Comparison of <i>in cellulo</i> enhancement of mutant Hex A enzyme activity in ATSD fibroblasts by selected PYR derivatives bearing modifications on the 5-phenyl group at various concentrations, i.e., determination of the level of “maximal increase” for each derivative. Panels (a) <b>5j</b>, circles, and <b>5h</b>, squares; (b) <b>5l</b>, circles, and <b>5k</b>, squares; (c) PYR, circles, and <b>5i</b>, squares; and (d) <b>5g</b>, circles, and <b>5f</b>, squares, all giving the graphical representations of the dose–response curves. Open symbols represent the β-galactosidase (Bgal) activity ratio, which serves as a control for toxicity, e.g., open circles, for each drug, and the same filled symbols, e.g., filled circles, represent the Hex A activity ratio between treated and mock treated cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Steady-state protein levels of the Hex α-subunit are increased to a greater degree in <b>5h</b>- versus PYR-treated patient fibroblasts. Lysates from ATSD patient fibroblasts were treated for 5 days with PYR (33 or 11 μg/mL) or <b>5h</b> (33 or 11 μg/mL) and analyzed by Western blotting using a proprietary rabbit polyclonal IgG against human Hex A, followed by anti-rabbit peroxidase conjugated IgG and chemiluminescence detection (ECL kit, Amsersham). Solid and open arrowheads denote position of bands corresponding to the mature (lysosomal) α- and β-subunits of Hex, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Increased colocalization (yellow) of Hex A (green) protein with the lysosomal marker LAMP1 (red), following the treatment of p.G269S/p.G269S α-Hex patient fibroblasts with either <b>5h</b> (33 μg/mL) or PYR (11 μg/mL). Nuclei are shown stained in blue (DAPI). Treated fibroblasts were permeabilized and probed with a proprietary rabbit polyclonal IgG anti-Hex A pre-absorbed with purified human Hex B and a LAMP1 mouse antibody. Primary antibody binding was visualized using the corresponding secondary Alexa Fluor 488 chicken anti-rabbit (green) or Alexa Fluor 594 chicken anti-mouse conjugated antibodies (red). Colocalization of Hex A and LAMP1 staining is shown on panels labeled MERGE.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/medium/jm-2014-017895_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Increased intracellular hydrolysis of a fluorescent derivative of GM2 ganglioside in ATSD patient fibroblasts treated with <b>5h</b> or PYR. Hydrolyzed fluorescent GM2 ganglioside derivatives isolated from patient fibroblasts pre-loaded with fluorescent GM2 were resolved by TLC. (A) Chromatograms showing the resolution of metabolized GM2 derivatives in the two phases generated by Folch extraction. (B) Quantification of hydrolyzed levels of ganglioside was derived from the optical density of the bands corresponding to GM3 in the aqueous phase and LacCer and GlcCer in the organic phase. (C) Relative Hex A activity (MUGS) in lysates prepared from the cells used to measure GM2 hydrolysis following treatment with DMSO (Ctrl), PYR, or <b>5h</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017895/20150605/images/large/jm-2014-017895_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017895&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85166" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85166" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kongsaeree, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khongsuk, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leartsakulpanich, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitnumsub, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarnchompoo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuthavong, Y.</span><span> </span><span class="NLM_article-title">Crystal structure of dihydrofolate reductase from Plasmodium vivax: pyrimethamine displacement linked with mutation-induced resistance</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">13046</span><span class="NLM_x">–</span> <span class="NLM_lpage">13051</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=13046-13051&author=P.+Kongsaereeauthor=P.+Khongsukauthor=U.+Leartsakulpanichauthor=P.+Chitnumsubauthor=B.+Tarnchompooauthor=M.+D.+Walkinshawauthor=Y.+Yuthavong&title=Crystal+structure+of+dihydrofolate+reductase+from+Plasmodium+vivax%3A+pyrimethamine+displacement+linked+with+mutation-induced+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKongsaeree%26aufirst%3DP.%26aulast%3DKhongsuk%26aufirst%3DP.%26aulast%3DLeartsakulpanich%26aufirst%3DU.%26aulast%3DChitnumsub%26aufirst%3DP.%26aulast%3DTarnchompoo%26aufirst%3DB.%26aulast%3DWalkinshaw%26aufirst%3DM.%2BD.%26aulast%3DYuthavong%26aufirst%3DY.%26atitle%3DCrystal%2520structure%2520of%2520dihydrofolate%2520reductase%2520from%2520Plasmodium%2520vivax%253A%2520pyrimethamine%2520displacement%2520linked%2520with%2520mutation-induced%2520resistance%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D13046%26epage%3D13051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Maegawa, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockley, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kok, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span> </span><span class="NLM_article-title">Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">9150</span><span class="NLM_x">–</span> <span class="NLM_lpage">9161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=9150-9161&author=G.+H.+Maegawaauthor=M.+Tropakauthor=J.+Buttnerauthor=T.+Stockleyauthor=F.+Kokauthor=J.+T.+Clarkeauthor=D.+J.+Mahuran&title=Pyrimethamine+as+a+potential+pharmacological+chaperone+for+late-onset+forms+of+GM2+gangliosidosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaegawa%26aufirst%3DG.%2BH.%26aulast%3DTropak%26aufirst%3DM.%26aulast%3DButtner%26aufirst%3DJ.%26aulast%3DStockley%26aufirst%3DT.%26aulast%3DKok%26aufirst%3DF.%26aulast%3DClarke%26aufirst%3DJ.%2BT.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DPyrimethamine%2520as%2520a%2520potential%2520pharmacological%2520chaperone%2520for%2520late-onset%2520forms%2520of%2520GM2%2520gangliosidosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D9150%26epage%3D9161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Clarke, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sathe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolodny, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raiman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropak, M. B.</span><span> </span><span class="NLM_article-title">An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants)</span> <span class="citation_source-journal">Mol. Genet. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">6</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1016%2Fj.ymgme.2010.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=20926324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2011&pages=6-12&author=J.+T.+Clarkeauthor=D.+J.+Mahuranauthor=S.+Satheauthor=E.+H.+Kolodnyauthor=B.+A.+Rigatauthor=J.+A.+Raimanauthor=M.+B.+Tropak&title=An+open-label+Phase+I%2FII+clinical+trial+of+pyrimethamine+for+the+treatment+of+patients+affected+with+chronic+GM2+gangliosidosis+%28Tay-Sachs+or+Sandhoff+variants%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay-Sachs or Sandhoff variants)</span></div><div class="casAuthors">Clarke, Joe T. R.; Mahuran, Don J.; Sathe, Swati; Kolodny, Edwin H.; Rigat, Brigitte A.; Raiman, Julian A.; Tropak, Michael B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Genetics and Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">6-12</span>CODEN:
                <span class="NLM_cas:coden">MGMEFF</span>;
        ISSN:<span class="NLM_cas:issn">1096-7192</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Late-onset GM2 gangliosidosis is an autosomal recessive, neurodegenerative, lysosomal storage disease, caused by deficiency of ss-hexosaminidase A (Hex A), resulting from mutations in the HEXA (Tay-Sachs variant) or the HEXB (Sandhoff variant) genes.  The enzyme deficiency in many patients with juvenile or adult onset forms of the disease results from the prodn. of an unstable protein, which becomes targeted for premature degrdn. by the quality control system of the smooth endoplasmic reticulum and is not transported to lysosomes.  In vitro studies have shown that many mutations in either the α or β subunit of Hex A can be partially rescued, i.e. enhanced levels of both enzyme protein and activity in lysosomes, following the growth of patient cells in the presence of the drug, pyrimethamine.  The objectives of the present clin. trial were to establish the tolerability and efficacy of the treatment of late-onset GM2 gangliosidosis patients with escalating doses of pyrimethamine, to a max. of 100 mg per day, administered orally in a single daily dose, over a 16-wk period .  The primary objective, tolerability, was assessed by regular clin. examns., along with a panel of hematol. and biochem. studies.  Although clin. efficacy could not be assessed in this short trial, treatment efficacy was evaluated by repeated measurements of leukocyte Hex A activity, expressed relative to the activity of lysosomal ss-glucuronidase.  A total of 11 patients were enrolled, 8 males and 3 females, aged 23 to 50 years.  One subject failed the initial screen, another was omitted from anal. because of the large no. of protocol violations, and a third was withdrawn very early as a result of adverse events which were not drug-related.  For the remaining 8 subjects, up to a 4-fold enhancement of Hex A activity at doses of 50 mg per day or less was obsd.  Addnl. marked individual variations in the pharmacokinetics of the drug among the patients were noted.  However, the study also found that significant side effects were experienced by most patients at or above 75 mg pyrimethamine per day.  We concluded that pyrimethamine treatment enhances leukocyte Hex A activity in patients with late-onset GM2 gangliosidosis at doses lower than those assocd. with unacceptable side effects.  Further plans are underway to extend these trials and to develop methods to assess clin. efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZVbvk_BJfMLVg90H21EOLACvtfcHk0liB-pahF25fqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFynsg%253D%253D&md5=67a35e0502c1a3a9c2fde98ebfe1aa40</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.ymgme.2010.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymgme.2010.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DJ.%2BT.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26aulast%3DSathe%26aufirst%3DS.%26aulast%3DKolodny%26aufirst%3DE.%2BH.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DRaiman%26aufirst%3DJ.%2BA.%26aulast%3DTropak%26aufirst%3DM.%2BB.%26atitle%3DAn%2520open-label%2520Phase%2520I%252FII%2520clinical%2520trial%2520of%2520pyrimethamine%2520for%2520the%2520treatment%2520of%2520patients%2520affected%2520with%2520chronic%2520GM2%2520gangliosidosis%2520%2528Tay-Sachs%2520or%2520Sandhoff%2520variants%2529%26jtitle%3DMol.%2520Genet.%2520Metab.%26date%3D2011%26volume%3D102%26spage%3D6%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Knight, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kottwitz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morant, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sjoberg, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrlich, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wustman, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandy, S.</span><span> </span><span class="NLM_article-title">Evidence that small molecule enhancement of beta-hexosaminidase activity corrects the behavioral phenotype in Dutch APP mice through reduction of ganglioside-bound Abeta</span> <span class="citation_source-journal">Mol. Psych.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1038%2Fmp.2014.135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=25349165" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=109-117&author=E.+M.+Knightauthor=H.+N.+Williamsauthor=A.+C.+Stevensauthor=S.+H.+Kimauthor=J.+C.+Kottwitzauthor=A.+D.+Morantauthor=J.+W.+Steeleauthor=W.+L.+Kleinauthor=K.+Yanagisawaauthor=R.+E.+Boydauthor=D.+J.+Lockhartauthor=E.+R.+Sjobergauthor=M.+E.+Ehrlichauthor=B.+A.+Wustmanauthor=S.+Gandy&title=Evidence+that+small+molecule+enhancement+of+beta-hexosaminidase+activity+corrects+the+behavioral+phenotype+in+Dutch+APP+mice+through+reduction+of+ganglioside-bound+Abeta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fmp.2014.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2014.135%26sid%3Dliteratum%253Aachs%26aulast%3DKnight%26aufirst%3DE.%2BM.%26aulast%3DWilliams%26aufirst%3DH.%2BN.%26aulast%3DStevens%26aufirst%3DA.%2BC.%26aulast%3DKim%26aufirst%3DS.%2BH.%26aulast%3DKottwitz%26aufirst%3DJ.%2BC.%26aulast%3DMorant%26aufirst%3DA.%2BD.%26aulast%3DSteele%26aufirst%3DJ.%2BW.%26aulast%3DKlein%26aufirst%3DW.%2BL.%26aulast%3DYanagisawa%26aufirst%3DK.%26aulast%3DBoyd%26aufirst%3DR.%2BE.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26aulast%3DSjoberg%26aufirst%3DE.%2BR.%26aulast%3DEhrlich%26aufirst%3DM.%2BE.%26aulast%3DWustman%26aufirst%3DB.%2BA.%26aulast%3DGandy%26aufirst%3DS.%26atitle%3DEvidence%2520that%2520small%2520molecule%2520enhancement%2520of%2520beta-hexosaminidase%2520activity%2520corrects%2520the%2520behavioral%2520phenotype%2520in%2520Dutch%2520APP%2520mice%2520through%2520reduction%2520of%2520ganglioside-bound%2520Abeta%26jtitle%3DMol.%2520Psych.%26date%3D2014%26volume%3D20%26spage%3D109%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sandhoff, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harzer, K.</span><span> </span><span class="NLM_article-title">Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">10195</span><span class="NLM_x">–</span> <span class="NLM_lpage">10208</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1523%2FJNEUROSCI.0822-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=23785136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVWmsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=10195-10208&author=K.+Sandhoffauthor=K.+Harzer&title=Gangliosides+and+gangliosidoses%3A+principles+of+molecular+and+metabolic+pathogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis</span></div><div class="casAuthors">Sandhoff, Konrad; Harzer, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10195-10208</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  Gangliosides are the main glycolipids of neuronal plasma membranes.  Their surface patterns are generated by coordinated processes, involving biosynthetic pathways of the secretory compartments, catabolic steps of the endolysosomal system, and intracellular trafficking.  Inherited defects in ganglioside biosynthesis causing fatal neurodegenerative diseases have been described so far almost exclusively in mouse models, whereas inherited defects in ganglioside catabolism causing various clin. forms of GM1- and GM2-gangliosidoses have long been known.  For digestion, gangliosides are endocytosed and reach intra-endosomal vesicles.  At the level of late endosomes, they are depleted of membrane-stabilizing lipids like cholesterol and enriched with bis(monoacylglycero)phosphate (BMP).  Lysosomal catabolism is catalyzed at acidic pH values by cationic sphingolipid activator proteins (SAPs), presenting lipids to their resp. hydrolases, electrostatically attracted to the neg. charged surface of the luminal BMP-rich vesicles.  Various inherited defects of ganglioside hydrolases, e.g., of β-galactosidase and β-hexosaminidases, and of GM2-activator protein, cause infantile (with tetraparesis, dementia, blindness) and different protracted clin. forms of GM1- and GM2-gangliosidoses.  Mutations yielding proteins with small residual catabolic activities in the lysosome give rise to juvenile and adult clin. forms with a wide range of clin. symptomatol.  Apart from patients' differences in their genetic background, clin. heterogeneity may be caused by rather diverse substrate specificities and functions of lysosomal hydrolases, multifunctional properties of SAPs, and the strong regulation of ganglioside catabolism by membrane lipids.  Currently, there is no treatment available for neuronal ganglioside storage diseases.  Therapeutic approaches in mouse models and patients with juvenile forms of gangliosidoses are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6JmmE4qqeXLVg90H21EOLACvtfcHk0li3s_7Fkf-vjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVWmsbbJ&md5=cd03f4156b362d648dd0752d067decc9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0822-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0822-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DSandhoff%26aufirst%3DK.%26aulast%3DHarzer%26aufirst%3DK.%26atitle%3DGangliosides%2520and%2520gangliosidoses%253A%2520principles%2520of%2520molecular%2520and%2520metabolic%2520pathogenesis%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D10195%26epage%3D10208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mahuran, D. J.</span><span> </span><span class="NLM_article-title">Biochemical consequences of mutations causing the GM2 gangliosidoses</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">1455</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1455&publication_year=1999&pages=105-138&author=D.+J.+Mahuran&title=Biochemical+consequences+of+mutations+causing+the+GM2+gangliosidoses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DBiochemical%2520consequences%2520of%2520mutations%2520causing%2520the%2520GM2%2520gangliosidoses%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1999%26volume%3D1455%26spage%3D105%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Leinekugel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conzelmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandhoff, K.</span><span> </span><span class="NLM_article-title">Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease</span> <span class="citation_source-journal">Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1007%2FBF00219337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=1348043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADyaK38XkvVOku70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1992&pages=513-23&author=P.+Leinekugelauthor=S.+Michelauthor=E.+Conzelmannauthor=K.+Sandhoff&title=Quantitative+correlation+between+the+residual+activity+of+beta-hexosaminidase+A+and+arylsulfatase+A+and+the+severity+of+the+resulting+lysosomal+storage+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease</span></div><div class="casAuthors">Leinekugel, P.; Michel, S.; Conzelman, E.; Sandhoff, K.</div><div class="citationInfo"><span class="NLM_cas:title">Human Genetics</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">513-23</span>CODEN:
                <span class="NLM_cas:coden">HUGEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0340-6717</span>.
    </div><div class="casAbstract">Inherited deficiencies of the same enzyme may have quite different clin. consequences.  Lysosomal storage diseases are a particularly striking example of this general phenomenon.  The syndromes caused by allelic mutations, e.g., of a lysosomal sphingolipid hydrolase, may range from most severe infantile diseases that lead to death in early childhood, over late-infantile, juvenile and adult forms to late-adult variants with an onset of symptoms in adulthood, slow progression of the disease and almost normal life span.  Clin. healthy probands with severely reduced activity (10-20% of normal) of a lysosomal enzyme (e.g., arylsulfatase A) were also identified ("pseudodeficiency").  A previously suggested model for the correlation between residual activity of a lysosomal enzyme and the turnover rate of its substrate(s) has been extended to a discussion of substrate accumulation rates in individual cells and whole organs.  With these considerations, much of the obsd. variability in age of onset and clin. phenotype, as well as the phenomenon of pseudo-deficiency, can be understood as the consequences of small differences in the residual activity of the affected enzyme.  To exptl. verify the basic assumptions on which this model rests, studies were performed in culture.  The radiolabeled substrates ganglioside GM2 and sulfatide were added to cultures of skin fibroblasts with different activities of β-hexosaminidase A or arylsulfatase A, resp., and their uptake and turnover measured.  In both series of expts., the correlation between residual enzyme activity and the turnover rate of the substrate was essentially as predicted: degrdn. increased steeply with residual activity, to reach the control level at a residual activity of ∼10-15% of normal.  All cells with an activity above this crit. threshold had a normal turnover.  Comparison of the results of these feeding studies with the clin. status of the donor of each cell line basically confirmed these notions but also revealed the limitations of the cell culture approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNSeW2cLgCEbVg90H21EOLACvtfcHk0lihbixisuPehQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XkvVOku70%253D&md5=437cbdfd9106018a942719a152e8bb85</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2FBF00219337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00219337%26sid%3Dliteratum%253Aachs%26aulast%3DLeinekugel%26aufirst%3DP.%26aulast%3DMichel%26aufirst%3DS.%26aulast%3DConzelmann%26aufirst%3DE.%26aulast%3DSandhoff%26aufirst%3DK.%26atitle%3DQuantitative%2520correlation%2520between%2520the%2520residual%2520activity%2520of%2520beta-hexosaminidase%2520A%2520and%2520arylsulfatase%2520A%2520and%2520the%2520severity%2520of%2520the%2520resulting%2520lysosomal%2520storage%2520disease%26jtitle%3DHum.%2520Genet.%26date%3D1992%26volume%3D88%26spage%3D513%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Tropak, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukovac, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonekawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakarchuk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span> </span><span class="NLM_article-title">A sensitive fluorescence-based assay for monitoring GM2 ganglioside hydrolysis in live patient cells and their lysates</span> <span class="citation_source-journal">Glycobiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=356-65&author=M.+B.+Tropakauthor=S.+W.+Bukovacauthor=B.+A.+Rigatauthor=S.+Yonekawaauthor=W.+Wakarchukauthor=D.+J.+Mahuran&title=A+sensitive+fluorescence-based+assay+for+monitoring+GM2+ganglioside+hydrolysis+in+live+patient+cells+and+their+lysates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DBukovac%26aufirst%3DS.%2BW.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DYonekawa%26aufirst%3DS.%26aulast%3DWakarchuk%26aufirst%3DW.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DA%2520sensitive%2520fluorescence-based%2520assay%2520for%2520monitoring%2520GM2%2520ganglioside%2520hydrolysis%2520in%2520live%2520patient%2520cells%2520and%2520their%2520lysates%26jtitle%3DGlycobiology%26date%3D2010%26volume%3D20%26spage%3D356%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bateman, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherney, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tropak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span> </span><span class="NLM_article-title">Crystal structure of beta-hexosaminidase B in complex with pyrimethamine, a potential pharmacological chaperone</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1421</span><span class="NLM_x">–</span> <span class="NLM_lpage">1429</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101443u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1421-1429&author=K.+S.+Batemanauthor=M.+M.+Cherneyauthor=D.+J.+Mahuranauthor=M.+Tropakauthor=M.+N.+James&title=Crystal+structure+of+beta-hexosaminidase+B+in+complex+with+pyrimethamine%2C+a+potential+pharmacological+chaperone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm101443u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101443u%26sid%3Dliteratum%253Aachs%26aulast%3DBateman%26aufirst%3DK.%2BS.%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26aulast%3DTropak%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DCrystal%2520structure%2520of%2520beta-hexosaminidase%2520B%2520in%2520complex%2520with%2520pyrimethamine%252C%2520a%2520potential%2520pharmacological%2520chaperone%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1421%26epage%3D1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Tarnchompoo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirichaiwat, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phupong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Intaraudom, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirawaraporn, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamchonwongpaisan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanichtanankul, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thebtaranonth, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuthavong, Y.</span><span> </span><span class="NLM_article-title">Development of 2,4-diaminopyrimidines as antimalarials based on inhibition of the S108N and C59R+S108N mutants of dihydrofolate reductase from pyrimethamine-resistant Plasmodium falciparum</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">1244</span><span class="NLM_x">–</span> <span class="NLM_lpage">1252</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010131q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=1244-1252&author=B.+Tarnchompooauthor=C.+Sirichaiwatauthor=W.+Phupongauthor=C.+Intaraudomauthor=W.+Sirawarapornauthor=S.+Kamchonwongpaisanauthor=J.+Vanichtanankulauthor=Y.+Thebtaranonthauthor=Y.+Yuthavong&title=Development+of+2%2C4-diaminopyrimidines+as+antimalarials+based+on+inhibition+of+the+S108N+and+C59R%2BS108N+mutants+of+dihydrofolate+reductase+from+pyrimethamine-resistant+Plasmodium+falciparum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm010131q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010131q%26sid%3Dliteratum%253Aachs%26aulast%3DTarnchompoo%26aufirst%3DB.%26aulast%3DSirichaiwat%26aufirst%3DC.%26aulast%3DPhupong%26aufirst%3DW.%26aulast%3DIntaraudom%26aufirst%3DC.%26aulast%3DSirawaraporn%26aufirst%3DW.%26aulast%3DKamchonwongpaisan%26aufirst%3DS.%26aulast%3DVanichtanankul%26aufirst%3DJ.%26aulast%3DThebtaranonth%26aufirst%3DY.%26aulast%3DYuthavong%26aufirst%3DY.%26atitle%3DDevelopment%2520of%25202%252C4-diaminopyrimidines%2520as%2520antimalarials%2520based%2520on%2520inhibition%2520of%2520the%2520S108N%2520and%2520C59R%252BS108N%2520mutants%2520of%2520dihydrofolate%2520reductase%2520from%2520pyrimethamine-resistant%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D1244%26epage%3D1252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, M. F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, K. P.</span><span> </span><span class="NLM_article-title">Structural studies on bio-active compounds.III. Re-examination of the hydrolysis of the antimalarial drug pyrimethamine and related derivatives and crystal-structure of a hydrolysis product</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2276</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1985&pages=2267-2276&author=R.+J.+Griffinauthor=C.+H.+Schwalbeauthor=M.+F.+G.+Stevensauthor=K.+P.+Wong&title=Structural+studies+on+bio-active+compounds.III.+Re-examination+of+the+hydrolysis+of+the+antimalarial+drug+pyrimethamine+and+related+derivatives+and+crystal-structure+of+a+hydrolysis+product"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DSchwalbe%26aufirst%3DC.%2BH.%26aulast%3DStevens%26aufirst%3DM.%2BF.%2BG.%26aulast%3DWong%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520studies%2520on%2520bio-active%2520compounds.III.%2520Re-examination%2520of%2520the%2520hydrolysis%2520of%2520the%2520antimalarial%2520drug%2520pyrimethamine%2520and%2520related%2520derivatives%2520and%2520crystal-structure%2520of%2520a%2520hydrolysis%2520product%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1985%26spage%3D2267%26epage%3D2276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Mark, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherney, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. N.</span><span> </span><span class="NLM_article-title">Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">327</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=327&publication_year=2003&pages=1093-1109&author=B.+L.+Markauthor=D.+J.+Mahuranauthor=M.+M.+Cherneyauthor=D.+Zhaoauthor=S.+Knappauthor=M.+N.+James&title=Crystal+structure+of+human+beta-hexosaminidase+B%3A+understanding+the+molecular+basis+of+Sandhoff+and+Tay-Sachs+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMark%26aufirst%3DB.%2BL.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26aulast%3DCherney%26aufirst%3DM.%2BM.%26aulast%3DZhao%26aufirst%3DD.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DJames%26aufirst%3DM.%2BN.%26atitle%3DCrystal%2520structure%2520of%2520human%2520beta-hexosaminidase%2520B%253A%2520understanding%2520the%2520molecular%2520basis%2520of%2520Sandhoff%2520and%2520Tay-Sachs%2520disease%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2003%26volume%3D327%26spage%3D1093%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Macauley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitworth, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debowski, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vocadlo, D. J.</span><span> </span><span class="NLM_article-title">O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">25313</span><span class="NLM_x">–</span> <span class="NLM_lpage">25322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1074%2Fjbc.M413819200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=15795231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslyltL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25313-25322&author=M.+S.+Macauleyauthor=G.+E.+Whitworthauthor=A.+W.+Debowskiauthor=D.+Chinauthor=D.+J.+Vocadlo&title=O-GlcNAcase+uses+substrate-assisted+catalysis%3A+kinetic+analysis+and+development+of+highly+selective+mechanism-inspired+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">O-GlcNAcase Uses Substrate-assisted Catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors</span></div><div class="casAuthors">Macauley, Matthew S.; Whitworth, Garrett E.; Debowski, Aleksandra W.; Chin, Danielle; Vocadlo, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">25313-25322</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The post-translational modification of serine and threonine residues of nucleocytoplasmic proteins with 2-acetamido-2-deoxy-D-glucopyranose (GlcNAc) is a reversible process implicated in multiple cellular processes.  The enzyme O-GlcNAcase catalyzes the cleavage of β-O-linked GlcNAc (O-GlcNAc) from modified proteins and is a member of the family 84 glycoside hydrolases.  The family 20 β-hexosaminidases bear no apparent sequence similarity yet are functionally related to O-GlcNAcase because both enzymes cleave terminal GlcNAc residues from glycoconjugates.  Lysosomal β-hexosaminidase is known to use substrate-assisted catalysis involving the 2-acetamido group of the substrate; however, the catalytic mechanism of human O-GlcNAcase is unknown.  By using a series of 4-methylumbelliferyl 2-deoxy-2-N-fluoroacetyl-β-D-glucopyranoside substrates, Taft-like linear free energy analyses of these enzymes indicates that O-GlcNAcase uses a catalytic mechanism involving anchimeric assistance.  Consistent with this proposal, 1,2-dideoxy-2'-methyl-α-D-glucopyranoso-[2,1-d]-Δ2'-thiazoline, an inhibitor that mimics the oxazoline intermediate proposed in the catalytic mechanism of family 20 glycoside hydrolases, is shown to act as a potent competitive inhibitor of both O-GlcNAcase (KII = 0.070 μM) and β-hexosaminidase (K = 0.070 μM).  A series of 1,2-dideoxy-2'-methyl-α-D-glucopyranoso-[2,1-d]-Δ2'-thiazoline analogs were prepd., and one inhibitor demonstrated a remarkable 1500-fold selectivity for O-GlcNAcase (KI = 0.230 μM) over β-hexosaminidase (KI = 340 μM).  These inhibitors are cell permeable and modulate the activity of O-GlcNAcase in tissue culture.  Because both enzymes have vital roles in organismal health, these potent and selective inhibitors of O-GlcNAcase should prove useful in studying the role of this enzyme at the organismal level without generating a complex chem. phenotype stemming from concomitant inhibition of β-hexosaminidase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf5bwGkGmPr7Vg90H21EOLACvtfcHk0ljmLS3usVCySg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslyltL4%253D&md5=77ec4816fd8d52878cb8025e9b5555e6</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M413819200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M413819200%26sid%3Dliteratum%253Aachs%26aulast%3DMacauley%26aufirst%3DM.%2BS.%26aulast%3DWhitworth%26aufirst%3DG.%2BE.%26aulast%3DDebowski%26aufirst%3DA.%2BW.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DVocadlo%26aufirst%3DD.%2BJ.%26atitle%3DO-GlcNAcase%2520uses%2520substrate-assisted%2520catalysis%253A%2520kinetic%2520analysis%2520and%2520development%2520of%2520highly%2520selective%2520mechanism-inspired%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25313%26epage%3D25322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Takakura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haque, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zandi-Nejad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4143</span><span class="NLM_x">–</span> <span class="NLM_lpage">4154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1093%2Fhmg%2Fddr338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=21821671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1yltrjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=4143-4154&author=A.+Takakuraauthor=E.+A.+Nelsonauthor=N.+Haqueauthor=B.+D.+Humphreysauthor=K.+Zandi-Nejadauthor=D.+A.+Frankauthor=J.+Zhou&title=Pyrimethamine+inhibits+adult+polycystic+kidney+disease+by+modulating+STAT+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways</span></div><div class="casAuthors">Takakura, Ayumi; Nelson, Erik A.; Haque, Nadeem; Humphreys, Benjamin D.; Zandi-Nejad, Kambiz; Frank, David A.; Zhou, Jing</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4143-4154</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Autosomal dominant polycystic kidney disease (ADPKD) is a commonly inherited disorder mostly caused by mutations in PKD1, encoding polycystin-1 (PC1).  The disease is characterized by development and growth of epithelium-lined cyst in both kidneys, often leading to renal failure.  There is no specific treatment for this disease.  Here, we report a sustained activation of the transcription factor signal transducer and activator of transcription 3 (STAT3) in ischemic injured and uninjured Pkd1 knockout polycystic kidneys and in human ADPKD kidneys.  Through a chem. library screen, we identified the anti-parasitic compd. pyrimethamine as an inhibitor of STAT3 function.  Treatment with pyrimethamine decreases cell proliferation in human ADPKD cells and blocks renal cyst formation in an adult and a neonatal PKD mouse model.  Moreover, we demonstrated that a specific STAT3 inhibitor, S3I-201, reduces cyst formation and growth in a neonatal PKD mouse model.  Our results suggest that PC1 acts as a neg. regulator of STAT3 and that blocking STAT3 signaling with pyrimethamine or similar drugs may be an attractive therapy for human ADPKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVEStaa2l9HbVg90H21EOLACvtfcHk0lgb-6foktsc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1yltrjP&md5=e5bae0f5d88e2e44da18b96ca0c46236</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddr338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddr338%26sid%3Dliteratum%253Aachs%26aulast%3DTakakura%26aufirst%3DA.%26aulast%3DNelson%26aufirst%3DE.%2BA.%26aulast%3DHaque%26aufirst%3DN.%26aulast%3DHumphreys%26aufirst%3DB.%2BD.%26aulast%3DZandi-Nejad%26aufirst%3DK.%26aulast%3DFrank%26aufirst%3DD.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DPyrimethamine%2520inhibits%2520adult%2520polycystic%2520kidney%2520disease%2520by%2520modulating%2520STAT%2520signaling%2520pathways%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2011%26volume%3D20%26spage%3D4143%26epage%3D4154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Reich, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span> </span><span class="NLM_article-title">Tracking STAT nuclear traffic</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1038%2Fnri1885" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=16868551" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1yisLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=602-612&author=N.+C.+Reichauthor=L.+Liu&title=Tracking+STAT+nuclear+traffic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tracking STAT nuclear traffic</span></div><div class="casAuthors">Reich, Nancy C.; Liu, Ling</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">602-612</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Accurate cellular localization is crucial for the effective function of most signaling mols. and nuclear translocation is central to the function of transcription factors.  The passage of large mols. between the cytoplasm and nucleus is restricted, and this restriction affords a mechanism to regulate transcription by controlling the access of transcription factors to the nucleus.  Here, the authors have focused on the signal transducer and activator of transcription (STAT) family of transcription factors.  The regulation of nuclear trafficking of STAT-family members is diverse.  Some STAT proteins constitutively shuttle between the nucleus and cytoplasm, whereas others require tyrosine phosphorylation for nuclear localization.  In either case, the regulation of nuclear trafficking can provide a target for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMmCEDYxf8Y7Vg90H21EOLACvtfcHk0lgb-6foktsc5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1yisLY%253D&md5=db8226f9ef065b39cd7708ac7db032af</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnri1885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1885%26sid%3Dliteratum%253Aachs%26aulast%3DReich%26aufirst%3DN.%2BC.%26aulast%3DLiu%26aufirst%3DL.%26atitle%3DTracking%2520STAT%2520nuclear%2520traffic%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2006%26volume%3D6%26spage%3D602%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Horvath, C. M.</span><span> </span><span class="NLM_article-title">STAT proteins and transcriptional responses to extracellular signals</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">502</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=496-502&author=C.+M.+Horvath&title=STAT+proteins+and+transcriptional+responses+to+extracellular+signals"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHorvath%26aufirst%3DC.%2BM.%26atitle%3DSTAT%2520proteins%2520and%2520transcriptional%2520responses%2520to%2520extracellular%2520signals%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2000%26volume%3D25%26spage%3D496%26epage%3D502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Hasilik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neufeld, E. F.</span><span> </span><span class="NLM_article-title">Biosynthesis of lysosomal enzymes in fibroblasts: synthesis as precursors of higher molecular weight</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">4937</span><span class="NLM_x">–</span> <span class="NLM_lpage">4945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1980&pages=4937-4945&author=A.+Hasilikauthor=E.+F.+Neufeld&title=Biosynthesis+of+lysosomal+enzymes+in+fibroblasts%3A+synthesis+as+precursors+of+higher+molecular+weight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHasilik%26aufirst%3DA.%26aulast%3DNeufeld%26aufirst%3DE.%2BF.%26atitle%3DBiosynthesis%2520of%2520lysosomal%2520enzymes%2520in%2520fibroblasts%253A%2520synthesis%2520as%2520precursors%2520of%2520higher%2520molecular%2520weight%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1980%26volume%3D255%26spage%3D4937%26epage%3D4945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Weiss, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanowitz, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittner, M.</span><span> </span><span class="NLM_article-title">Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS</span> <span class="citation_source-journal">J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">580</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1093%2Finfdis%2F157.3.580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=3343528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A280%3ADyaL1c7ktVCjug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=1988&pages=580-583&author=L.+M.+Weissauthor=C.+Harrisauthor=M.+Bergerauthor=H.+B.+Tanowitzauthor=M.+Wittner&title=Pyrimethamine+concentrations+in+serum+and+cerebrospinal+fluid+during+treatment+of+acute+Toxoplasma+encephalitis+in+patients+with+AIDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS</span></div><div class="casAuthors">Weiss L M; Harris C; Berger M; Tanowitz H B; Wittner M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">580-3</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQgCg2G22RuB0cLvDNbOD4DfW6udTcc2eZMLnFTrEX4_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c7ktVCjug%253D%253D&md5=2b7b653b65a9a9ae825114fee39ca9b9</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F157.3.580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F157.3.580%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26aulast%3DHarris%26aufirst%3DC.%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DTanowitz%26aufirst%3DH.%2BB.%26aulast%3DWittner%26aufirst%3DM.%26atitle%3DPyrimethamine%2520concentrations%2520in%2520serum%2520and%2520cerebrospinal%2520fluid%2520during%2520treatment%2520of%2520acute%2520Toxoplasma%2520encephalitis%2520in%2520patients%2520with%2520AIDS%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1988%26volume%3D157%26spage%3D580%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Pajouhesh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, G. R.</span><span> </span><span class="NLM_article-title">Medicinal chemical properties of successful central nervous system drugs</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1602%2Fneurorx.2.4.541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=16489364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=541-553&author=H.+Pajouheshauthor=G.+R.+Lenz&title=Medicinal+chemical+properties+of+successful+central+nervous+system+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemical properties of successful central nervous system drugs</span></div><div class="casAuthors">Pajouhesh Hassan; Lenz George R</div><div class="citationInfo"><span class="NLM_cas:title">NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">541-53</span>
        ISSN:<span class="NLM_cas:issn">1545-5343</span>.
    </div><div class="casAbstract">Fundamental physiochemical features of CNS drugs are related to their ability to penetrate the blood-brain barrier affinity and exhibit CNS activity.  Factors relevant to the success of CNS drugs are reviewed.  CNS drugs show values of molecular weight, lipophilicity, and hydrogen bond donor and acceptor that in general have a smaller range than general therapeutics.  Pharmacokinetic properties can be manipulated by the medicinal chemist to a significant extent.  The solubility, permeability, metabolic stability, protein binding, and human ether-ago-go-related gene inhibition of CNS compounds need to be optimized simultaneously with potency, selectivity, and other biological parameters.  The balance between optimizing the physiochemical and pharmacokinetic properties to make the best compromises in properties is critical for designing new drugs likely to penetrate the blood brain barrier and affect relevant biological systems.  This review is intended as a guide to designing CNS therapeutic agents with better drug-like properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_ncsy3yuEinl8icjszYl0fW6udTcc2eZMLnFTrEX4_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28%252FpvVKqsg%253D%253D&md5=0815084e2d107b9243b785d0782dfc3a</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1602%2Fneurorx.2.4.541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1602%252Fneurorx.2.4.541%26sid%3Dliteratum%253Aachs%26aulast%3DPajouhesh%26aufirst%3DH.%26aulast%3DLenz%26aufirst%3DG.%2BR.%26atitle%3DMedicinal%2520chemical%2520properties%2520of%2520successful%2520central%2520nervous%2520system%2520drugs%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D541%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kofron, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baclawski, L. M.</span><span> </span><span class="NLM_article-title">Convenient method for estimation of alkyllithium concentrations</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1879</span><span class="NLM_x">–</span> <span class="NLM_lpage">1880</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00872a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1976&pages=1879-1880&author=W.+G.+Kofronauthor=L.+M.+Baclawski&title=Convenient+method+for+estimation+of+alkyllithium+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo00872a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00872a047%26sid%3Dliteratum%253Aachs%26aulast%3DKofron%26aufirst%3DW.%2BG.%26aulast%3DBaclawski%26aufirst%3DL.%2BM.%26atitle%3DConvenient%2520method%2520for%2520estimation%2520of%2520alkyllithium%2520concentrations%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1976%26volume%3D41%26spage%3D1879%26epage%3D1880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Russell, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchings, G. H.</span><span> </span><span class="NLM_article-title">2,4-diaminopyrimidines as antimalarials.III. 5-aryl derivatives</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1951</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">3763</span><span class="NLM_x">–</span> <span class="NLM_lpage">3770</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01152a060" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1951&pages=3763-3770&author=P.+B.+Russellauthor=G.+H.+Hitchings&title=2%2C4-diaminopyrimidines+as+antimalarials.III.+5-aryl+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fja01152a060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01152a060%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DP.%2BB.%26aulast%3DHitchings%26aufirst%3DG.%2BH.%26atitle%3D2%252C4-diaminopyrimidines%2520as%2520antimalarials.III.%25205-aryl%2520derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1951%26volume%3D73%26spage%3D3763%26epage%3D3770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Rogers, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leanza, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarett, L. H.</span><span> </span><span class="NLM_article-title">Antiparasitic agents 0.1. Some new 2,4-diaminopyrimidines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1492</span><span class="NLM_x">–</span> <span class="NLM_lpage">1494</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01362a045" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1957&pages=1492-1494&author=E.+F.+Rogersauthor=W.+J.+Leanzaauthor=L.+H.+Sarett&title=Antiparasitic+agents+0.1.+Some+new+2%2C4-diaminopyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo01362a045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01362a045%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DE.%2BF.%26aulast%3DLeanza%26aufirst%3DW.%2BJ.%26aulast%3DSarett%26aufirst%3DL.%2BH.%26atitle%3DAntiparasitic%2520agents%25200.1.%2520Some%2520new%25202%252C4-diaminopyrimidines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1957%26volume%3D22%26spage%3D1492%26epage%3D1494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xin, Z. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosogof, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, L. T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szczepankiewicz, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaszubska, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, V. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falls, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span> </span><span class="NLM_article-title">Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: Side chain exploration</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1864</span><span class="NLM_x">–</span> <span class="NLM_lpage">1868</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1864-1868&author=B.+Liuauthor=M.+Liuauthor=Z.+L.+Xinauthor=H.+Y.+Zhaoauthor=M.+D.+Serbyauthor=C.+Kosogofauthor=L.+T.+J.+Nelsonauthor=B.+G.+Szczepankiewiczauthor=W.+Kaszubskaauthor=V.+G.+Schaeferauthor=H.+D.+Fallsauthor=C.+W.+Linauthor=C.+A.+Collinsauthor=H.+L.+Shamauthor=G.+Liu&title=Optimization+of+2%2C4-diaminopyrimidines+as+GHS-R+antagonists%3A+Side+chain+exploration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DZ.%2BL.%26aulast%3DZhao%26aufirst%3DH.%2BY.%26aulast%3DSerby%26aufirst%3DM.%2BD.%26aulast%3DKosogof%26aufirst%3DC.%26aulast%3DNelson%26aufirst%3DL.%2BT.%2BJ.%26aulast%3DSzczepankiewicz%26aufirst%3DB.%2BG.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DSchaefer%26aufirst%3DV.%2BG.%26aulast%3DFalls%26aufirst%3DH.%2BD.%26aulast%3DLin%26aufirst%3DC.%2BW.%26aulast%3DCollins%26aufirst%3DC.%2BA.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DLiu%26aufirst%3DG.%26atitle%3DOptimization%2520of%25202%252C4-diaminopyrimidines%2520as%2520GHS-R%2520antagonists%253A%2520Side%2520chain%2520exploration%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1864%26epage%3D1868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Barlin, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotecka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieckmann, K. H.</span><span> </span><span class="NLM_article-title">Potential antimalarials.XXII. Some 2,4-diamino-5-(3- and 4-trifluoromethylphenyl and 3,4-methylenedioxyphenyl)pyrimidines</span> <span class="citation_source-journal">Aus. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">647</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADyaK28XltlKgs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1996&pages=647-650&author=G.+B.+Barlinauthor=B.+Koteckaauthor=K.+H.+Rieckmann&title=Potential+antimalarials.XXII.+Some+2%2C4-diamino-5-%283-+and+4-trifluoromethylphenyl+and+3%2C4-methylenedioxyphenyl%29pyrimidines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Potential antimalarials. XXII. Some 2,4-diamino-5-(3- and 4-trifluoromethylphenyl and 3,4-methylenedioxyphenyl)pyrimidines</span></div><div class="casAuthors">Barlin, Gordon B.; Kotecka, Barbara; Rieckmann, Karl H.</div><div class="citationInfo"><span class="NLM_cas:title">Australian Journal of Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">647-650</span>CODEN:
                <span class="NLM_cas:coden">AJCHAS</span>;
        ISSN:<span class="NLM_cas:issn">0004-9425</span>.
    
            (<span class="NLM_cas:orgname">Commonwealth Scientific and Industrial Research Organization</span>)
        </div><div class="casAbstract">A series of 10 pyrimethamine analogs contg. 3'- and 4'-trifluoromethyl and 3',4'-methylenedioxy groups, I (R = Et, H, Me, CF3, X = 4'-Cl, 3'-CF3, 4'-CF3, 3'4'-OCH2O), has been prepd. and tested for in vitro antimalarial activity against the FC-27 and k-1 isolates of Plasmodium falciparum.  Several of these compds. were almost as active as pyrimethamine against the drug-sensitive FC-27 isolate, and like pyrimethamine, they were much less active against the drug-resistant k-1 isolate.  The 4'-trifluoromethyl compds., however, showed much smaller differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7QAb_TwV7vLVg90H21EOLACvtfcHk0liVhUFjRZ4M7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlKgs70%253D&md5=c7b36bb08a27bca3e3e4670f9142f272</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarlin%26aufirst%3DG.%2BB.%26aulast%3DKotecka%26aufirst%3DB.%26aulast%3DRieckmann%26aufirst%3DK.%2BH.%26atitle%3DPotential%2520antimalarials.XXII.%2520Some%25202%252C4-diamino-5-%25283-%2520and%25204-trifluoromethylphenyl%2520and%25203%252C4-methylenedioxyphenyl%2529pyrimidines%26jtitle%3DAus.%2520J.%2520Chem.%26date%3D1996%26volume%3D49%26spage%3D647%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Trattner, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchings, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharefkin, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elion, G. B.</span><span> </span><span class="NLM_article-title">Deamination studies on pyrimidine and condensed pyrimidine systems</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2677</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01032a047" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1964&pages=2674-2677&author=R.+B.+Trattnerauthor=G.+H.+Hitchingsauthor=D.+M.+Sharefkinauthor=G.+B.+Elion&title=Deamination+studies+on+pyrimidine+and+condensed+pyrimidine+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo01032a047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01032a047%26sid%3Dliteratum%253Aachs%26aulast%3DTrattner%26aufirst%3DR.%2BB.%26aulast%3DHitchings%26aufirst%3DG.%2BH.%26aulast%3DSharefkin%26aufirst%3DD.%2BM.%26aulast%3DElion%26aufirst%3DG.%2BB.%26atitle%3DDeamination%2520studies%2520on%2520pyrimidine%2520and%2520condensed%2520pyrimidine%2520systems%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1964%26volume%3D29%26spage%3D2674%26epage%3D2677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Russell, P. B.</span><span> </span><span class="NLM_article-title">The effects of substitution on the ultra-violet absorption spectra of phenylpyrimidines</span> <span class="citation_source-journal">J. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1954</span><span class="NLM_x">, </span> <span class="NLM_fpage">2951</span><span class="NLM_x">–</span> <span class="NLM_lpage">2955</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1954&pages=2951-2955&author=P.+B.+Russell&title=The+effects+of+substitution+on+the+ultra-violet+absorption+spectra+of+phenylpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DP.%2BB.%26atitle%3DThe%2520effects%2520of%2520substitution%2520on%2520the%2520ultra-violet%2520absorption%2520spectra%2520of%2520phenylpyrimidines%26jtitle%3DJ.%2520Chem.%2520Soc.%26date%3D1954%26spage%3D2951%26epage%3D2955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Mahuran, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowden, J. A.</span><span> </span><span class="NLM_article-title">The subunit and polypeptide structure of hexosaminidases from human placenta</span> <span class="citation_source-journal">Can. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1139%2Fv80-046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=7378875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADyaL3cXktVejsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1980&pages=287-294&author=D.+Mahuranauthor=J.+A.+Lowden&title=The+subunit+and+polypeptide+structure+of+hexosaminidases+from+human+placenta"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">The subunit and polypeptide structure of hexosaminidases from human placenta</span></div><div class="casAuthors">Mahuran, D.; Lowden, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-94</span>CODEN:
                <span class="NLM_cas:coden">CJBIAE</span>;
        ISSN:<span class="NLM_cas:issn">0008-4018</span>.
    </div><div class="casAbstract">Hexosaminidases (HEX) are tetrameric enzymes composed of either 2 dimers of β chains (HEX B) or a β-chain dimer and an α-chain dimer (HEX A).  HEX S contains only α chains.  HEX A and B of human placenta were purified >6000-fold.  From HEX A was prepd. HEX B and a more anodically migrating HEX S.  After either extensive redn. and alkylation or performic acid oxidn., HEX B gave only a single protein band in polyacrylamide gel electrophoresis in Na dodecyl sulfate; HEX A consistently gave 2 bands indicating it contained chains of 2 different mol. wts.  To rule out hydrophobic interaction, mol. wt. was detd. by gel filtration in 6M guanidine-HCl.  Complete disulfide bond breakage was ensured by using a harsher redn. and alkylation procedure than previously employed.  The results were then confirmed by the use of 2 performic acid oxidn. techniques, the stronger method resulting in extensive peptide bond oxidn.  Samples of HEX A under redn. and alkylation or the weaker performic acid oxidn. procedure again chromatographed as 2 approx. equal peaks (50,000 and 25,000).  HEX B, and the HEX B prepd. from HEX A, resulted in one 25,000-dalton peak.  HEX S chromatographed as a single 50,000 peak.  Thus, either the α chain in HEX has a mol. wt. of 50,000 with one α chain per α subunit or 2 25,000-dalton chains are united by a nondisulfide crosslink (e.g., an isopeptide bond).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUxiiQEc2_ArVg90H21EOLACvtfcHk0lgcGLKWwAdGXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXktVejsb8%253D&md5=eef1e07aecfb9284e1077d89eed06824</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1139%2Fv80-046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fv80-046%26sid%3Dliteratum%253Aachs%26aulast%3DMahuran%26aufirst%3DD.%26aulast%3DLowden%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520subunit%2520and%2520polypeptide%2520structure%2520of%2520hexosaminidases%2520from%2520human%2520placenta%26jtitle%3DCan.%2520J.%2520Biochem.%26date%3D1980%26volume%3D58%26spage%3D287%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tropak, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guiral, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withers, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D.</span><span> </span><span class="NLM_article-title">Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">13478</span><span class="NLM_x">–</span> <span class="NLM_lpage">13487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=13478-13487&author=M.+B.+Tropakauthor=S.+P.+Reidauthor=M.+Guiralauthor=S.+G.+Withersauthor=D.+Mahuran&title=Pharmacological+enhancement+of+beta-hexosaminidase+activity+in+fibroblasts+from+adult+Tay-Sachs+and+Sandhoff+Patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DReid%26aufirst%3DS.%2BP.%26aulast%3DGuiral%26aufirst%3DM.%26aulast%3DWithers%26aufirst%3DS.%2BG.%26aulast%3DMahuran%26aufirst%3DD.%26atitle%3DPharmacological%2520enhancement%2520of%2520beta-hexosaminidase%2520activity%2520in%2520fibroblasts%2520from%2520adult%2520Tay-Sachs%2520and%2520Sandhoff%2520Patients%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D13478%26epage%3D13487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Tropak, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornhaber, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigat, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maegawa, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuske, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coales, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamuro, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahuran, D. J.</span><span> </span><span class="NLM_article-title">Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on beta-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2650</span><span class="NLM_x">–</span> <span class="NLM_lpage">2662</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=2650-2662&author=M.+B.+Tropakauthor=G.+J.+Kornhaberauthor=B.+A.+Rigatauthor=G.+H.+Maegawaauthor=J.+D.+Buttnerauthor=J.+E.+Blanchardauthor=C.+Murphyauthor=S.+J.+Tuskeauthor=S.+J.+Coalesauthor=Y.+Hamuroauthor=E.+D.+Brownauthor=D.+J.+Mahuran&title=Identification+of+pharmacological+chaperones+for+Gaucher+disease+and+characterization+of+their+effects+on+beta-glucocerebrosidase+by+hydrogen%2Fdeuterium+exchange+mass+spectrometry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTropak%26aufirst%3DM.%2BB.%26aulast%3DKornhaber%26aufirst%3DG.%2BJ.%26aulast%3DRigat%26aufirst%3DB.%2BA.%26aulast%3DMaegawa%26aufirst%3DG.%2BH.%26aulast%3DButtner%26aufirst%3DJ.%2BD.%26aulast%3DBlanchard%26aufirst%3DJ.%2BE.%26aulast%3DMurphy%26aufirst%3DC.%26aulast%3DTuske%26aufirst%3DS.%2BJ.%26aulast%3DCoales%26aufirst%3DS.%2BJ.%26aulast%3DHamuro%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DE.%2BD.%26aulast%3DMahuran%26aufirst%3DD.%2BJ.%26atitle%3DIdentification%2520of%2520pharmacological%2520chaperones%2520for%2520Gaucher%2520disease%2520and%2520characterization%2520of%2520their%2520effects%2520on%2520beta-glucocerebrosidase%2520by%2520hydrogen%252Fdeuterium%2520exchange%2520mass%2520spectrometry%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D2650%26epage%3D2662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Lees, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, S.</span><span> </span><span class="NLM_article-title">A simple procedure for the preparation of brain sulphatides</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1959</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5017895&amp;key=10.1111%2Fj.1471-4159.1959.tb13169.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5017895&amp;key=13655088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5017895&amp;key=1%3ACAS%3A528%3ADyaG1MXnvVajuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1959&pages=9-18&author=M.+Leesauthor=J.+Folchauthor=G.+H.+Stanleyauthor=S.+Carr&title=A+simple+procedure+for+the+preparation+of+brain+sulphatides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A simple procedure for the preparation of brain sulfatides</span></div><div class="casAuthors">Lees, M. B.; Folch-Pi, J.; Sloane Stanley, G. H.; Carr, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1959</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">No. 1</span>),
    <span class="NLM_cas:pages">9-18</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">cf. C.A. 46, 159i.  Sulfatides from bovine brain white matter were isolated by distribution of the lipides between two phases of a series of related solvent systems.  Two main fractions were obtained; one fraction was essentially pure sulfatide (sulfatide A), the other contained both S and P and was sepd. into a P-free sulfatide fraction and a phosphatide mixt. by passage through a Florisil column.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmxInaKZTeLbVg90H21EOLACvtfcHk0lgcGLKWwAdGXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG1MXnvVajuw%253D%253D&md5=46e3718def3885fa8502e6a238f01747</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1959.tb13169.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1959.tb13169.x%26sid%3Dliteratum%253Aachs%26aulast%3DLees%26aufirst%3DM.%26aulast%3DFolch%26aufirst%3DJ.%26aulast%3DStanley%26aufirst%3DG.%2BH.%26aulast%3DCarr%26aufirst%3DS.%26atitle%3DA%2520simple%2520procedure%2520for%2520the%2520preparation%2520of%2520brain%2520sulphatides%26jtitle%3DJ.%2520Neurochem.%26date%3D1959%26volume%3D4%26spage%3D9%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a href="/doi/suppl/10.1021/jm5017895">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_55770"></div></div></div></div></div><hr /></hr><p class="last">Figure S1, comparison of <i>in cellulo</i> enhancement of wild-type Hex A enzyme activity in fibroblasts treated with either DMSO, PYR, or <b>5h</b> (<i>n</i> = 4); spectral data and NMR spectra for representative compounds. The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/jm5017895">10.1021/jm5017895</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5017895/suppl_file/jm5017895_si_001.pdf">jm5017895_si_001.pdf (1.41 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5017895&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-11%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm5017895%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5017895" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0d3664dc3221c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
